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ABSTRACT 
Cell membranes display a complex, dynamic organization of lipids, proteins 
and other small molecules. This organization may arise from varied protein-protein 
interactions including interactions between receptors, effectors and ligand molecules 
or from formation of specialized domains within the plasma membrane such as lipid 
rafts. The involvement of integrin cell surface receptors in membrane complexes is 
intensively known. Integrins’ interactions with other components in these complexes 
can alter many signal transduction cascades, thus modulating integrins’ own 
functions and affecting various cellular processes. Integrins are heterodimers formed 
by the non-covalent association of an α- and a β-subunit. Each subunit consists of a 
single transmembrane domain, a large extracellular domain and a short cytoplasmic 
domain. While ligand binding to integrin extracellular domains allows transmission of 
signals into the cell (outside-in signaling), binding of cytoskeletal proteins to integrin 
cytoplasmic domains permits inside-out signaling. In this way, integrins mediate 
bidirectional signaling across the plasma membrane and control a variety of cellular 
processes including cell adhesion, mobility, growth, survival, proliferation, and 
differentiation. The work described in this dissertation aims to achieve a better 
understanding of membrane organization by identifying the factors that affect 
integrin dynamics. Using molecular biology and fluorescence microscopy 
techniques, we have measured integrin clustering and diffusion properties under 
altered environments such as reduced membrane cholesterol levels, reduced 
cytoplasmic protein concentrations and reduced membrane protein concentrations. 
Additionally, we have also studied the effects of post-translational modifications on 
integrin dynamics.  The fluorescence techniques used in this work include 
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fluorescence resonance energy transfer (FRET) to study integrin clustering, 
fluorescence recovery after photobleaching (FRAP) and single particle tracking 
(SPT) to study integrin diffusion. A number of cytoplasmic and membrane proteins 
were identified that alter integrin diffusion and clustering. Reducing the levels of 
cholesterol from the cell membrane resulted in more mobile integrins and affected 
diffusion of integrins in confined domains. Removing a potential palmitoylation site in 
αPS2CβPS integrins resulted in more mobile integrins. The role of other proteins, 
cholesterol and palmitoylation in altering integrin diffusion and clustering may be the 
result of partitioning of integrins into lipid nanodomains, which are heterogeneous 
regions in the cell membrane containing higher concentration of lipids and proteins 
as compared to the bulk membrane and play a very important role in cell signaling. 
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DISSERTATION OVERVIEW 
The work described in this dissertation aims to achieve a deeper 
understanding of integrin organization and diffusion using microscopic and molecular 
biology techniques. We have focused on studying the properties and behavior of an 
important family of cell membrane receptors called integrins. The dissertation begins 
with a background on cell signaling, integrins, and fluorescence microscopy in 
Chapter 1. Chapter 2 describes the role of membrane proteins in affecting integrin 
clustering and diffusion. The membrane proteins targeted in this work include Notch, 
epidermal growth factor receptor (EGFR), and platelet-derived growth 
factor/vascular endothelial growth factor-related receptor (pvr). The dissertation 
continues with looking at the effects of cholesterol in influencing integrin diffusion in 
Chapter 3. Here, partial substitution of cholesterol with its stereoisomer, 
epicholesterol, was used as a strategy to study the mechanism behind the diffusion 
changes observed. Chapter 4 explains the effects of post-translational modification 
called palmitoylation on integrin diffusion in the cell membrane using SPT and 
FRAP. Finally, Chapter 5 concludes the dissertation by summarizing the findings 
from the preceding chapters and presents future prospects and applications of the 
research done. 
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CHAPTER 1 
GENERAL INTRODUCTION 
 
1.1 CELL SIGNALING  
Cells must interact and adapt to their environment in order to function 
properly. This requires the transfer of information across the cell membrane, which is 
achieved by a diversity of receptors present on the cell surface. Receptors initiate 
signals in response to a variety of extracellular stimuli (e.g. ligand binding) and then 
transmit the signal/information to downstream molecules, beginning a cascade of 
events [1]. The complexity in signal transduction arises with the crosstalk between 
multiple signaling pathways. In addition several protein-protein, protein-lipid 
interactions exist that could add to this complexity. Signaling events in cells are 
tightly controlled since any subtle defects or errors could lead to serious diseases 
such as hypertension, heart diseases, diabetes, mental illness or cancer [1]. 
 
1.2 THE INTEGRIN FAMILY OF CELL MEMBRANE RECEPTORS 
Integrins comprise a major family of cell membrane receptors that are highly 
conserved among different species including sponges, Caenorhabditis elegans, 
Drosophila melanogaster, chicken, zebrafish and mammals [2]. They are 
heterodimeric glycoproteins composed of two non-covalently associated subunits (α 
and β). Each of these subunits has a single transmembrane domain, short 
cytoplasmic tail, and a large extracellular domain. The extracellular domain of 
integrins binds a wide variety of ligands (outside-in signaling); their cytoplasmic 
domain interacts with various cytoskeletal proteins (inside-out signaling). This 
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bidirectional signaling allows integrins to link the internal and external environment of 
the cells and thus regulate important cellular processes including cell growth, 
motility, adhesion, survival, differentiation [3].  
 
1.2.1 Integrin structure 
The X-ray diffraction crystal structure of integrins shows the presence of 
multiple domains in the extracellular portion of each subunit [4]. In general there are 
4 subdomains in the α subunit: a β propeller domain, a thigh domain and two calf 
domains. Many integrins also have an additional inserted (I)-domain in the α subunit. 
The β subunit contains 8 subdomains: an I-like domain, a plexin-semaphorin-integrin 
(PSI) domain, a hybrid domain, four EGF repeats, and a membrane proximal β tail 
domain. The globular headpiece is formed by the β-propeller domain of the α-
subunit and the I-like domain of the β-subunit and contains the ligand-binding site at 
the interface between the α and β subunit. The transmembrane (TM) and 
cytoplasmic domains of integrins are short (10-70 amino acid residues in 
cytoplasmic domain and 20-25 residues in transmembrane domain) and are not 
directly involved in ligand binding but play an important role in transducing 
conformational changes in integrins.  
 
1.2.2 Integrin signaling and dynamics 
Integrin signaling is dependent on their dynamics such as changes in 
conformations, changes in clustering and/or changes in diffusion [5]. In the inactive 
state, integrins exist in a bent (“closed”) conformation and have a low affinity for 
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ligand (Figure 1.1 A). Signal transmission from inside the cell leads to integrin 
activation and altered conformation to the extended form for high affinity ligand 
binding (Figure 1.1 B). Another mechanism of signal transmission is integrin 
clustering. Individual integrin heterodimers laterally associate with one another at the 
membrane surface; this affects their ligand binding affinity. Integrin clustering is not 
only dependent on the interaction between individual integrins but it is also 
influenced by the interaction of integrins with other proteins (cytoplasmic/membrane) 
and/or integrins’ association with lipid nanodomains. Several studies have 
suggested that integrins physically associate with tetraspanins, and this may affect 
their clustering [6-8]. A recent study revealed the role of cytoskeletal proteins such 
as talin, vinculin, FAK etc. in influencing integrin clustering [9]. Diffusion affects 
signal transmission by regulating integrin distribution on the membrane surface and 
their interaction with other membrane components. The experimental diffusion 
coefficients are lower than predicted by the Saffman Delbrück equation [10]. There 
could be several possible mechanisms for this observation: interactions with the 
extracellular matrix and the cytoskeleton, confinement in membrane nanodomains, 
hindrance due to other membrane proteins etc. Thus, it is apparent that one 
membrane component may affect the clustering and diffusion properties of another, 
which could lead to changes in signaling events.  
 
1.3 FLUORESCENCE MICROSCOPY  
The most widely used technique in the study of integrin dynamics has been 
fluorescence microscopy. Unlike many other non-optical imaging approaches (e.g., 
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atomic force microscopy, electron microscopy), fluorescence microscopy is non-
invasive. Another advantage of fluorescence microscopy is its sensitivity; a single 
molecule or nanoparticle can be imaged in some experiments.  Fluorescence 
imaging uses light of specific wavelength to excite fluorescent species in the sample 
of interest.  The phenomenon begins with the absorption of light to generate an 
excited electronic state.  As electrons relax back to the ground state, the molecule 
loses vibrational energy followed by the emission of longer wavelength light (Figure 
1.2 A). This emitted light can be separated from the excitation light using specific 
filters that only allow the emission wavelengths to pass through.  
Molecules exhibiting fluorescence are called fluorophores. Many marine 
organisms produce fluorescent proteins. One of the very first fluorescent proteins to 
be discovered was GFP (green fluorescent protein) that was isolated from jellyfish 
Aequorea victoria [11]. In biological applications, these fluorescent proteins can be 
tagged to the proteins of interest, hence allowing non-invasive fluorescence imaging 
in the live cells.  
 Many variations of fluorescence microscopy have been used to study 
integrins including total internal reflection fluorescence microscopy (TIRF) [12], 
fluorescence resonance energy transfer (FRET) [13, 14], fluorescence recovery after 
photobleaching (FRAP) [15, 16], single particle tracking (SPT) [17, 18], chromophore 
assisted light inactivation (CALI) [19], fluorescence-lifetime imaging microscopy 
(FLIM) [20] etc. In this dissertation, integrin clustering was studied using FRET, 
ensemble integrin diffusion was studied using FRAP, and SPT was used to measure 
the diffusion of individual integrins. These techniques are described in detail below. 
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1.3.1 Fluorescence resonance energy transfer (FRET) 
The most significant drawback in wide-field imaging is the diffraction limit [21]. 
While large-scale integrin clusters (>200 nm) can be observed using conventional 
fluorescence microscopy, small scale integrin clusters (<200 nm) being below the 
diffraction limit require a subdiffraction spatial resolution technique like fluorescence 
resonance energy transfer (FRET) [22]. FRET is a technique that provides a spatial 
resolution of ~1-10 nm. The process involves non-radiative energy transfer from a 
donor fluorophore to an acceptor fluorophore via dipole-dipole coupling (Figure 1.2 
B). The energy transfer occurs when the donor and acceptor fluorophores are in 
close proximity (~1-10nm) and there is a significant overlap between the donor’s 
emission and acceptor’s excitation spectrum. The efficiency of energy transfer 
increases as the sixth power of the distance between the donor and acceptor 
decreases. Therefore, FRET is especially useful in detecting small changes in 
molecular proximity.  Several FRET studies to measure integrin clustering utilized 
fluorophores directly attached to integrin subunits. Directly attaching the 
fluorophores could alter the properties of integrins and at the same time affect 
integrin’s interactions with other cellular components. Additionally, studying protein 
mutants with this approach could be laborious and time consuming. Recently, Smith 
et al. developed an improved FRET assay that can measure the protein clustering 
properties without the need to attach the fluorophores directly to the integrin and 
also is less time consuming [23]. Figure 1.3 shows the schematic of this FRET assay 
to measure clustering of αPS2CβPS integrins. The assay uses FRET reporters 
expressed along with the full-length integrins in the cells. FRET reporters contain 
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fluorescent proteins (donor and acceptor) fused to the transmembrane and 
cytoplasmic domains of the βPS integrin subunit. Due to the sequence homology 
with integrins, these FRET reporters cluster along with the integrins. Therefore, the 
energy transfer between these reporters as measured from FRET can be related to 
the clustering of integrins. Moreover, FRET reporters do not alter the ligand binding 
properties of coexpressed integrins [23] . 
 
1.3.2 Fluorescence recovery after photobleaching (FRAP) 
FRAP is a technique used to measure the lateral mobility and diffusion of 
membrane lipids and proteins [24]. Typically, the protein of interest is fluorescently 
tagged with a fluorescent protein such as GFP (green fluorescent protein). The 
fluorescent tag is chosen such that it has high quantum yield and has low tendency 
of photobleaching with low illumination intensities. Briefly, fluorophores in a region of 
interest on the cell are irreversibly photobleached using a high-intensity laser. The 
diffusion of surrounding molecules into the previously photobleached area is then 
monitored over time using low intensity light. An example of a series of FRAP 
images and the resulting recovery curve is shown in Figure 1.4. Two parameters can 
be obtained from FRAP experiments: the percentage of proteins diffusing and the 
diffusion coefficient of the protein, which is related to diffusion time (τd) as : 
                                                𝐷 = 𝜔!β 4𝜏! 
where ω is the radius of the focused circular laser beam at the e-2 intensity and β is a 
correction factor for the amount of photobleaching. FRAP has been extensively used 
to study integrin dynamics in living cells. Diffusion of αLβ2 integrins (leukocyte 
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function-associated antigen-1 [LFA-1]) as measured by FRAP demonstrated that 
different receptor conformations have distinct diffusion profiles [25]. The results 
revealed the effects of cell activation on lateral mobility of the receptor and showed 
that cell activation, as a result of conformational changes causes an increase in the 
diffusion of LFA-1 integrin. The role of integrin signaling in E-cadherin dynamics was 
revealed using a FRAP-based approach [26]. Knockdown of β1 integrin and its 
downstream effector molecule FAK, led to an increase in diffusion of E-cadherin. 
FRAP has also been used to measure the binding rate constants of integrins in focal 
adhesions [27].  
 
1.3.3 Single particle tracking (SPT) 
There are disadvantages associated with the use of FRAP to measure protein 
diffusion [28]. FRAP is an ensemble technique that averages out the diffusion of 
hundreds of proteins. Therefore, FRAP experiments are unable to measure the 
heterogeneity in the diffusion properties of proteins in the cell membrane. SPT has 
several advantages over FRAP measurements. By providing one order of magnitude 
higher spatial resolution than FRAP, SPT overcomes the disadvantages posed by 
FRAP.  Unlike FRAP, SPT monitors the motion of individual proteins and thus can 
measure heterogeneity in the diffusion properties of receptors.  
 SPT uses probes to label proteins of interest followed by their detection as a 
function of time [29]. A variety of probes have been used to measure receptor 
diffusion by SPT (e.g., gold particles, fluorescent proteins, organic dyes and 
quantum dots) [30]. Ligand conjugated gold particles have the advantage of being 
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photostable. However, analysis using gold particles is restricted by the large size of 
the particles that have been used in many experiments (i.e., 40nm).  Fluorescent 
probes including organic dyes provide specific labeling but suffer from 
photobleaching. Quantum dots (QD) have become the most popular probes for 
single particle tracking because of their photophysical properties [29]. These are 
nanometer-sized semiconductor materials commonly made of CdSe or ZnS. Due to 
their small size; QDs have much improved photophysical properties than organic 
fluorophores. They are 10-20 times brighter and 100-1000 times more photostable 
than many organic fluorophore [31]. Additionally the emission wavelength of 
quantum dots can be tuned by changing their size, providing the ability to change 
the emission for numerous applications. Table 1 compares the structure and 
properties of different probes used in SPT experiments. 
 SPT measurements on LFA-1 integrin have provided important details on the 
dynamics of this protein, which were previously missing [17]. Using SPT, it was 
determined that the cytoplasmic tail of the β subunit is not the only part of the 
integrin involved in cytoskeleton interactions as was previously thought. Existence of 
additional interactions was suggested possibly via the α cytoplasmic integrin domain 
as evident by the restricted diffusion of mutant LFA-1 lacking the complete β as 
measured by SPT. Antibody conjugated QDs were used to quantitatively 
demonstrate changes in the integrin dynamics during osteogenic differentiation of 
human BMPCs [32].  
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Table 1.1 Comparison of different SPT probes.  
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Figure 1.1 (A) Bent and (B) extended conformation of integrin receptor as seen in 
the crystal structures. Adapted from [33]. 
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Figure 1.2 Jablonski diagrams depicting the process of (A) fluorescence and (B) 
FRET.  
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Figure 1.3 Schematic of a FRET assay used to study integrin clustering. (Top) 
Integrins expressed with FRET reporters containing fluorescent proteins fused to the 
transmembrane and cytoplasmic domains of the βPS integrin subunit. (Bottom) 
FRET controls containing fluorescent proteins fused to the transmembrane and 
cytoplasmic domains of a protein with no sequence homology to integrins. 
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Figure 1.4 Select images of a cell expressing a fluorophore obtained in a FRAP 
experiment (right panel). Resulting recovery curve plotted by measuring the 
fluorescent intensity in the bleached region (green circle) is shown in the left panel. 
Scale bar represents 5 µm. 
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CHAPTER 2 
UNRAVELING THE ROLE OF MEMBRANE PROTEINS 
NOTCH, PVR, AND EGFR IN ALTERING INTEGRIN 
DIFFUSION AND CLUSTERING 
A paper published in Analytical and Bioanalytical Chemistry 2012, 404 (8), 2339-48* 
Neha Arora, Dipak Mainali and Emily A. Smith 
2.1 ABSTRACT 
 The role of three membrane proteins in altering the diffusion and clustering of 
integrin receptors has been measured. Integrins are membrane proteins responsible 
for integrating intracellular and extracellular signaling events and anchoring cells to 
the extracellular matrix. The methodology used to elucidate the role of other 
membrane proteins in altering integrin diffusion and clustering combines 
fluorescence microscopy with RNA interference (RNAi), which is a technique to 
reduce the expression of a target protein. The three RNAi-targeted membrane 
proteins were epidermal growth factor receptor (EGFR), platelet-derived growth 
factor/vascular endothelial growth factor-related receptor (Pvr), and Notch. Real-time 
polymerase chain reaction or quantitative immunocytochemistry was used to 
measure a reduction in mRNA or protein concentration after RNAi treatment, 
respectively. Fluorescence recovery after photobleaching showed that reducing the 
concentration of EGFR or Notch results in less constrained integrin diffusion and, 
 
*Reprinted with permission from The Journal of Analytical and Bioanalytical 
Chemistry Copyright © Springer 2012 
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in the case of Notch RNAi, 4 % more mobile integrins. Fluorescence resonance 
energy transfer measurements performed before and after RNAi treatments indicate 
that clustering decreases for wild-type integrin, but increases for a high-ligand-
affinity integrin mutant after reducing the expression of EGFR, Pvr, or Notch. A 
model to explain the measured changes after reducing the expression of these three 
membrane proteins involving cholesterol-enriched nanodomains is proposed.  
 
2.2  INTRODUCTION 
Protein clustering and the formation of heterogeneous domains, such as lipid 
nanodomains, synapses, clathrin-coated pits, or caveolae, result in a complex, 
dynamic organization of the plasma membrane [1]. This organization often has 
functional significance [2, 3]. For example, receptor clustering is one mechanism for 
signal transmission across the cell membrane, and changes in diffusion affect the 
rate at which membrane components can relocate to respond to new stimuli. One 
membrane protein may affect the diffusion or clustering of other membrane species 
through direct protein–protein contacts or an indirect mechanism. One protein may 
affect the diffusion or clustering of another even if they do not make direct contact 
since the cell membrane is a crowded environment, composed of up to ~80 % 
protein [4]. There may also be an adapter protein(s) that indirectly connects 
membrane proteins. The role of many membrane proteins in altering the clustering 
and diffusion properties of other receptors remain largely uncharacterized despite 
the utility of knowing how one membrane component affects others. 
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A family of cell surface receptors, termed integrins, is crucial to cell adhesion, 
mobility, growth, survival, proliferation, and differentiation [5, 6]. Integrins contain a 
noncovalently associated α- and β-subunit with a large extracellular domain, a 
transmembrane domain, and a short cytoplasmic domain [6]. Integrin binding to 
extracellular ligand and cytoskeletal proteins permits signal transduction across the 
membrane [6]. Another mechanism for integrin function is association with other 
membrane components to form complexes on the cell surface [7]. The disruption of 
these complexes affects integrin functions, including integrin-mediated cell 
migration, cell adhesion, and even the surface expression of integrins [7].  
Three additional receptors involved in cell signaling are epidermal growth 
factor receptor (EGFR) [8], platelet derived growth factor/vascular endothelial growth 
factor related receptor (Pvr) [9], and Notch [10]. EGFR and Pvr belong to the 
receptor tyrosine kinase (RTK) family [11]. Evidence of direct RTK interaction with 
different members of the integrin family is from co-immunoprecipitation studies [12]. 
For example, αvβ3 integrins directly associate with platelet-derived growth factor 
and vascular endothelial growth factor receptors [12]. Additionally, α6β4 integrins 
have been shown to associate with EGFR in keratinocytes [13]. Integrins have been 
suggested to interact with RTKs in lipid nanodomains [14]. Baron et al. [15] observed 
that in differentiating myelin-forming oligodendrocytes, the platelet-derived growth 
factor receptor becomes sequestered in lipid nanodomains that also contain laminin, 
α6β1 integrins, and other downstream signaling molecules. There is also evidence 
of a common link between integrin and RTK signaling pathways through the 
cytoplasmic protein focal adhesion kinase [16]. Notch, a single transmembrane 
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receptor, localizes with β1 integrins and EGFR in lipid nanodomains [17]. There is 
coordination between integrin, Notch, and EGFR signaling pathways in many cellular 
contexts [17, 18]. 
Herein, two main questions are addressed: (1) how do EGFR, Pvr, and Notch 
membrane proteins influence integrin clustering and (2) how do these membrane 
proteins influence integrin lateral diffusion? Both wild-type and a high-ligand-affinity 
integrin mutant were studied. The methodology used to address these questions 
(Figure 2.1) is similar to that recently described to elucidate the role of cytoplasmic 
proteins in altering receptor diffusion and clustering [19, 20]. Briefly, a target 
membrane protein’s expression was selectively reduced and the subsequent 
changes in integrin properties measured using fluorescence microscopy. In contrast 
to other methods for reducing protein concentration, such as small-molecule 
inhibitors and antibody microinjection, RNA interference (RNAi) is both facile and 
selective [21, 22]. The measurements were performed in live Drosophila S2 cells 
expressing αPS2CβPS integrins. The Drosophila integrin shares 41 % (β) or 35 % 
(α) sequence homology to a corresponding vertebrate integrin [23, 24]. Previous 
work with Drosophila integrins revealed that their ligand-binding affinity increased in 
the presence of Mn2+ or with select protein mutations [25]. The increased ligand 
affinity associated with Mn2+ or protein mutation was later measured for vertebrate 
αIIbβ3 integrins [26]. The Drosophila cell culture system has less functional 
redundancy, which simplifies the experimental approach [27]. In contrast to 
vertebrate siRNA, RNAi in Drosophila cells is robust, often with no off-target 
reductions in the protein expression reported [28]. Thus, the studies reported herein 
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advance the understanding of how the dynamics and the organization of the integrin 
receptor family are altered as a consequence of the presence of other membrane 
proteins. 
 
2.3  EXPERIMENTAL METHODS 
2.3.1 Cell preparation 
All experiments were performed using transformed S2 cells cultured as 
described previously [19]. For fluorescence resonance energy transfer (FRET) 
experiments, cells were co-transfected to express αPS2CβPS or 
αPS2CβPS(V409D) integrins and FRET reporter peptides [29]. Cells used for 
fluorescence recovery after photobleaching (FRAP) experiments to measure integrin 
diffusion expressed αPS2CβPS-Venus yellow fluorescent protein or 
αPS2CβPS(V409D)-Venus fusion proteins [20]. FRAP experiments to measure lipid 
diffusion used cells expressing unmodified integrins [30]. The expression of 
exogenous proteins was mediated by a heat shock promoter [24]. Cells were 
subjected to heat shock for 30 min at 36 °C and allowed to recover for 3 h at 22 °C. 
Cells were then centrifuged at 600 x g for 3 min and resuspended in serum-free 
medium to a final concentration of 3 x 105 cells/mL. For lipid diffusion 
measurements, the cell suspension contained 11.9 µM carbocyanine-based DiD 
(1,1′-dioctadecyl-3,3,3′,3′-tetramethylindodicarbocyanine perchlorate; Invitrogen). 
Cells were allowed to spread on RBB-tiggrin (0.5 µg/mL) coated glass slides for 1 h 
at room temperature in serum-free medium [19]. The serum-free medium was 
replaced with 20 mM BES Tyrodes buffer (200 mM BES,1.37 M NaCl, 29 mM KCl, 1 
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% (w/v) glucose, 1 % (w/v) bovine serum albumin) before taking fluorescence 
measurements to avoid background fluorescence from the medium. 
 
2.3.2 RNA interference 
As previously described, RNAi probes were prepared using the 
MEGASCRIPT T7 Transcription Kit (Ambion, Austin, TX) [19]. The cells were 
incubated with 10 µg dsRNA for 4 days at 22 °C to allow for the turnover of the 
target protein before performing a microscopy or real-time polymerase chain 
reaction (RT-PCR) experiment [31, 32]. The RNAi probe IDs were EGFR 
BKN50635, Pvr HFA03080, and Notch HFA18685 [31, 32]. These probes have no 
reported off-target reductions. A statistically significant 10–12 % increase in cell 
death was measured on days 2–4 after Pvr RNAi. 
 
2.3.3 RNA isolation and RT-PCR 
Total polyadenylated mRNA was extracted from the transformed S2 cell 
lysates using the Dynabeads mRNA DIRECT™ Kit (Invitrogen 610.12) following the 
manufacturer’s protocol. mRNA was quantified at 260 nm on a spectrophotometer, 
and 250–600 ng of the extracted mRNA in a final volume of 20 µL was reverse-
transcribed using a High Capacity RNA-to-cDNA kit (Applied Biosystems). RT-PCR 
reactions were performed on a Roche Light-Cycler 480 (Roche Applied Science) 
system using Applied Biosystems TaqMan Gene Expression Assays 
(EGFR:Dm01841622_g1; Pvr: Dm01803618_g1; Notch: Dm01841974_g1; Mys 
(βPS): Dm01843060_m1; reference gene: Dm01820605_g1). Standard curves were 
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constructed using serial dilutions of S2 genomic DNA ranging from 8.64 to 86,400 
pg/µL. For the gene expression assays that could not detect genomic DNA (Pvr: 
Dm01803618_g1 and Mys(βPS):Dm01843060_m1) , the target’s amplification 
efficiency was assumed to be equal to that of the reference gene. Plasma 
membrane calcium ATPase [33] was used as a reference gene. Every measurement 
was performed in duplicate. Relative expression and statistical analyses were 
performed using the software REST 2009 (Qiagen, Hilden, Germany).  
 
2.3.4 FRET microscopy 
Cells were imaged on a Nikon Eclipse TE2000U microscope using a 
Coolsnap CCD (Roper Scientific Photometrics, Pleasanton, CA) and a 0.95 
numerical aperture x60 magnification objective. The CCD was set to bin 8x8 pixels. 
Fluorescence was collected using a mercury lamp illumination and three filter 
configurations, described previously [19]. FRET values (Eapp) were obtained after 
background subtraction was performed on all images using an average intensity 
from a region of the interest without cells (the white region of interest in Figure 2.2 is 
an example) and calculated for each pixel using Eq. 1. E!"" =    !!"! !!!" !!!! !!!" !!!!!"! !!!" !!!! !!!"!! !!!            (1) 
where IDA, IAA, and IDD are the intensities obtained from the images with the FRET, 
acceptor, or donor filters, respectively. G is an instrument-specific parameter that 
correlates the decrease in donor fluorescence with the increase in acceptor 
fluorescence due to energy transfer. In this case, G is 1.4. The factors a, b, c, and d 
have been previously described [19] and did not vary with the donor or acceptor 
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fluorescent protein expression: a = 0.32 ± 0.01; b = 0.117 ± 0.006; c = 0.15 ± 0.01; d 
= 0.276 ± 0.009. No cellular autofluorescence was measured in the donor, acceptor, 
or FRET images. The FRET data are presented as histograms, where each 
histogram is constructed from a minimum of 15,000 pixels representing 50 cells to 
capture heterogeneity from cell to cell. The pixel frequency was normalized to the 
total number of pixels that generated a positive FRET value above the background. 
To determine the FRET background, Eapp was calculated using cells that expressed 
only the donor or acceptor fluorescent protein. In this case, no energy transfer can 
be assumed. The upper 95 % confidence interval of the mean of the log-transformed 
data is defined as the limit between the background and the detectable FRET [34]. 
The log transform of the Eapp data is required since the data are not normally 
distributed [19]. FRET measurements were performed after two replicate RNAi 
treatments. Statistical differences among the histograms were examined using 
Kolmogorov–Smirnov tests with the program MATLAB (The MathWorks, Natick, 
MA).  
 
2.3.5 FRAP microscopy 
FRAP data were collected consistent with previously described procedures 
[20, 35]. Five images were collected prior to photobleaching, and then a series of 
images were collected after photobleaching to monitor the fluorescence recovery. 
For FRAP data analysis, fluorescence intensities were obtained from the 
photobleached and a non-photobleached region of the plasma membrane for every 
image in the recovery series using the software ImageJ 1.38v. An example of select 
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images from a series is shown in Figure 2.3. All fluorescence intensities were 
background subtracted (Figure 2.3, blue region of interest) and normalized with 
respect to the pre-photobleached intensity. The ratio between the photobleached 
(Figure 2.3, red region of interest) to the non-photobleached intensity (Figure 2.3, 
green region of interest) was calculated to account for the slight photobleaching from 
the mercury lamp during the recovery phase. Recovery curves from at least ten 
replicate experiments on different cells were averaged. The averaged data were fit 
to three diffusion models previously described by Feder et al. [36] using Igor Pro 
(version 4.0) with fits weighted to the standard error of the pre-bleached intensities. 
The diffusion models are based on Eq. 2. 
                                 F t = !!!!!" !!! ! !!+ tt1 2 α        (2)                   
where t is the time, Fin is the fluorescence intensity at an infinite recovery time, F0 is 
the initial fluorescence intensity after photobleaching, and t1/2 is the time required for 
50 % fluorescence to recover in the bleached area; the time exponent α is a 
measure of the diffusion constraints. In the first model (Brownian), diffusion is 
assumed to be Brownian (α = 1) with an immobile fraction (Fin < 1). The second 
model (constrained) is a time-dependent diffusion model that assumes complete (Fin 
= 1) but constrained diffusion (α < 1). The third model (constrained with an immobile 
fraction) is also a time-dependent diffusion model assuming constrained diffusion (α 
< 1) with an immobile fraction (Fin < 1). The parameters obtained from the fit to the 
FRAP data were used to calculate the diffusion coefficients, mobile fraction, and 
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immobile fraction as previously reported [36]. Reduced chi-square values were 
calculated to determine the best fit to the FRAP data. The best-fit model generates a 
reduced chi-square close to 1. Brownian diffusion is assumed to be the best-fit 
model when two models produce the same reduced chi-square. 
 
2.3.6 Quantitative immunocytochemistry 
The expression levels of integrin, EGFR, and Notch were measured in cells 
by immunocytochemistry. Cells were spread on a ligand/bovine serum albumin 
(BSA)-coated slide for 1 h, fixed with 4 % paraformaldehyde in phosphate-buffered 
saline (PBS) for 10 min, washed with PBS, and then incubated in 10 % fetal calf 
serum in PBS (EGFR and Notch antibodies) or M3 medium plus 2 mgmL−1 BSA 
(integrin antibody) for 20 min at room temperature. Cells were then incubated with 
the primary antibody for 20 min and washed again with PBS. The primary antibodies 
were mouse monoclonal anti-βPS (CF.6G11, 1:10 diluted in M3 medium plus 2 mg 
mL−1 BSA); rabbit polyclonal anti-EGFR (d-298, 1:50 diluted in 1.5 % fetal calf serum 
in PBS; Santa Cruz Biotechnology, Santa Cruz, CA); and mouse monoclonal anti-
Notch (C458.2H, 1:50 diluted in 1.5 % fetal calf serum in PBS; Developmental 
Studies Hybridoma Bank, University of Iowa, Iowa City, IA). After washing again with 
PBS, cells were incubated with species-specific Alexa Fluor 647-conjugated 
secondary antibodies (1:200, Invitrogen) diluted in 1.5% fetal calf serum in PBS for 
20 min. Cells were imaged using a x100 1.49 Apo TIRF objective with mercury lamp 
illumination and conditions suitable for quantitative measurements [37]. The average 
fluorescence intensities for all pixels from a region of interest (similar to the one 
  
 
26 
represented in Figure 2.2) were measured, background-subtracted, and averaged 
for a minimum of 30 cells before or after RNAi treatment. 
 
2.4 RESULTS AND DISCUSSION 
2.4.1 Establishing integrin diffusion and clustering at endogenous membrane 
protein concentrations 
The purpose of this study was to elucidate the role of EGFR, Pvr, and Notch 
in altering integrin diffusion and clustering by measuring changes that occur after 
selectively reducing their membrane concentration (Figure 2.1). To begin, clustering 
and diffusion were measured at endogenous protein concentrations. The average 
integrin FRAP curve representing ten replicate measurements is shown in Figure 
2.4a (black symbols). The data were best fit to the diffusion model describing an 
immobile, non-diffusing fraction of integrins and a mobile integrin fraction with 
constrained, non-Brownian diffusion (Figure 2.4a, dotted line and inset). The 
parameters extracted from the best-fit model (Table 2.1, no RNAi) show that 67 % of 
the integrin is diffusing with a time-dependent diffusion coefficient of 3.2 ± 0.2 x10−9 
cm2/s at 1 s. At 50 s, diffusion slows by ~80 % to 0.6 ± 0.3x10-9 cm2/s. Constraints to 
integrin diffusion and the presence of an immobile fraction may arise from 
interactions with cytoplasmic, membrane, or extracellular protein(s); integrins 
partitioning between domains smaller than the probed area and the bulk membrane; 
interactions with the microscope slide; or a combination of the aforementioned 
factors. Lipid diffusion at endogenous membrane protein concentrations has a larger 
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mobile fraction (0.94 ± 0.01) and a less constrained diffusion than measured for 
integrins (Figure 2.4c and Table 2.1). 
A FRET assay utilizing transmembrane peptides was employed to measure 
integrin clustering [29]. Two integrin-expressing cell lines were used for these 
experiments: (1) one containing FRET reporter peptides with transmembrane 
domains that cluster with integrins (FRET reporter) and (2) a second containing 
FRET control peptides that are capable of clustering, but lack any sequence 
homology with the integrins (FRET control). Both sets of FRET peptides contain the 
same Venus yellow fluorescent protein donor and dsRED acceptor. Energy transfer 
measured with the FRET control peptides is assumed to be non-integrin specific. At 
native membrane protein concentrations, there is a difference between the Eapp (i.e., 
FRET calculated from Eq. 1) histograms for cells expressing the FRET reporter 
peptides and the FRET control peptides (solid black line in Figure 2.5a, c, 
respectively). One difference is that the histogram for the cell line that expresses the 
FRET reporter peptides has a significant population with energy transfer values 
greater than ~0.2, whereas the cell line with the FRET control peptides does not. 
 
2.4.2 Quantification of mRNA and protein concentration before and after RNA 
interference 
In order to elucidate the role of other membrane proteins in altering integrin 
diffusion and clustering, the expression of the target membrane proteins was 
selectively reduced by RNAi. After the appropriate RNAi treatment, there is a 
degradation of the corresponding mRNA, which leads to a reduction in the protein 
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concentration. Compared to cells that did not receive an RNAi treatment, there is a 
statistically significant 49–78 % decrease in all target mRNAs after the respective 
RNAi treatments (Table 2.2, relative target mRNA expression αβ). Changes in 
protein expression were measured by performing quantitative immunocytochemistry 
for the target proteins with available antibodies for the S2 cell line used in this study. 
Immunocytochemistry results show that there is a 21 % (Notch) or a 35 % (EGFR) 
reduction in the target protein’s membrane expression after the respective RNAi 
treatment (Table 2.2, relative target protein expression αβ). The decrease in mRNA 
concentration qualitatively correlates with a decrease in protein expression, as 
expected, although there was no quantitative correlation between mRNA and protein 
concentration similar to what has been reported in the literature [38–40]. 
Perturbations to the composition of one membrane component may affect the 
concentration of other membrane components through altered membrane turnover 
[41, 42]. Therefore, integrin expression was also measured after EGFR, Pvr, or 
Notch RNAi treatment. The membrane concentration of integrins was measured 
using immunocytochemistry conditions that did not enable the antibody to bind to 
intracellular integrin. There was a 23, 20, and a 52% reduction in integrin membrane 
concentration after Pvr, Notch, and EGFR RNAi treatments, respectively (Table 2.2, 
relative integrin expression αβ). A previous report shows that there were no 
statistically significant changes in the integrin membrane composition after RNAi 
treatments against a number of cytoplasmic proteins [20]. The mechanism for the 
reduction in integrin membrane concentration after EGFR, Pvr, or Notch RNAi 
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treatment is most likely through an altered membrane turnover. The consequences 
of this reduction will be further discussed below.   
 
2.4.3 Integrin diffusion at reduced concentrations of the target membrane 
protein 
Similar to integrin diffusion at endogenous membrane protein concentrations, 
the best-fit diffusion model for all FRAP curves measured after RNAi was 
constrained diffusion with an immobile fraction (Figure 2.4a). After EGFR and Notch 
RNAi, integrin diffusion is faster and less constrained, as revealed by the 2.9- and 
1.3-fold slower diffusion coefficients at longer analysis times compared to the 5.3-
fold slower diffusion coefficient at 50 s before RNAi (Table 2.1). Plausible reasons 
for the reduction in integrin diffusion constraints are an overall decrease in the total 
membrane protein concentration, alterations in membrane nanodomains, or protein–
protein interactions. Reductions in the membrane integrin concentrations are not a 
likely explanation for the faster, less constrained integrin diffusion since Pvr RNAi 
results in a reduction in integrin membrane concentration, but no statistically 
significant change in the diffusion coefficient. Similarly, Pvr and Notch RNAi 
treatments result in lipid diffusion that is less constrained, as determined by the best-
fit diffusion model or the diffusion coefficients (Table 2.1), yet this correlates with the 
changes in integrin diffusion only for Notch RNAi. 
Notch RNAi results in a small 4 % statistically significant increase in the 
integrin mobile fraction. It has been shown that reducing the concentration of select 
extracellular or cytoplasmic proteins results in an increase in the integrin mobile 
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fraction by up to 27 % [20]. In contrast, the studied membrane proteins have a 
negligible effect on the integrin mobile fraction. Whether reducing the concentration 
of a membrane or cytoplasmic protein increases the integrin mobile fraction depends 
on whether there is a direct or indirect interaction with the protein, whether the 
cytoplasmic/membrane species is mobile or immobile, and whether the duration of 
the interaction is shorter or longer than the FRAP timescale. 
 
2.4.4 Integrin clustering at reduced concentrations of the target membrane 
protein 
Figure 2.5a, c shows the histograms of Eapp after the indicated RNAi 
treatments for the cell line expressing FRET reporter or FRET control peptides, 
respectively. Reducing the expression of EGFR, Pvr, or Notch produced a 
statistically significant decrease in energy transfer for the FRET reporter peptides 
compared to when the membrane proteins are expressed at endogenous levels 
(Figure 2.5d), indicating less integrin clustering. The population measured at 
endogenous membrane protein concentrations with Eapp values greater than ~0.4 
was nearly eliminated after the RNAi treatments. It is possible that this is the result 
of the lower concentration of integrins in the cell membrane after the RNAi 
treatments. Interestingly, the decrease in energy transfer measured for the FRET 
reporter peptides is the opposite of the increase in energy transfer measured for the 
FRET control peptides after EGFR and Pvr RNAi. The decrease in energy transfer 
measured for the FRET reporter peptides implies that clustering of integrins 
decreases after EGFR and Pvr RNAi despite other changes in the membrane that 
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may be driving the clustering of other species represented by the FRET control 
peptides. 
Reduced concentrations of the target membrane proteins included in this 
study may alter the composition or dynamics of the membrane nanodomains or alter 
the partitioning of integrins within the membrane nanodomains. Evidence supporting 
this hypothesis is the change in integrin clustering after reducing the membrane 
concentration of cholesterol, a key component of some membrane nanodomains 
[35]. When the membrane cholesterol concentration was reduced, ~50 % less 
clustering was measured for αPS2CβPS integrins, the same integrins used in this 
study [35]. The results reported herein after reducing the concentration of EGFR, 
Pvr, or Notch are consistent with the decreased clustering measured after 
cholesterol depletion and suggest that the targeted membrane proteins may alter the 
composition of the nanodomains or integrin partitioning between the nanodomains 
and the bulk membrane.  
Alterations to integrin clustering may be partially responsible for the changes 
in integrin diffusion after Notch or EGFR RNAi. The Saffman and Delbrück [43] 
model of lateral mobility predicts a weak dependence of the crosssectional radius (r) 
on diffusion (D): D∝ln(1/r). The lateral diffusion coefficient is predicted to modestly 
increase by 1.7- to 2.3-fold when membrane protein clusters decrease to half their 
original size. The increase in integrin diffusion measured after EGFR and Notch 
RNAi discussed above may in part be the result of smaller/fewer integrin clusters, 
but is not likely the sole cause for these changes. 
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2.4.5 Effect of integrin ligand affinity on clustering and diffusion at reduced 
concentrations of the target membrane protein 
Previous studies showed that β1 integrin activation (a poorly defined term that 
generally means an increase in ligand affinity prior to encountering the ligand) [26, 
44] may affect Notch activation through EGFR [17]. Therefore, it is a reasonable 
hypothesis that integrin ligand affinity may affect the role Notch and EGFR, and 
perhaps Pvr, have in altering integrin clustering and diffusion. To test this 
hypothesis, clustering and diffusion were measured in a cell line expressing a high-
ligand-affinity integrin mutant. This integrin has a one point (V409D) mutation, as 
previously described [45]. Similar to what was measured for the wildtype integrin-
expressing cell line, a reduction in both mRNA and the target protein expression was 
measured after RNAi in the high-ligand-affinity integrin-expressing cell line (Table 
2.2), although the magnitude of the change was not always consistent. In contrast to 
the wild-type integrin expressing cell line, no statistically significant change at the 95 
% confidence level was measured in the membrane expression of the high-ligand-
affinity integrin after EGFR, Pvr, or Notch RNAi as compared to the concentration 
before RNAi. 
The FRAP curves for the cell line expressing the high-ligand-affinity integrin 
are shown in Figure 2.4b. Consistent with all the integrin FRAP curves measured, 
the constrained diffusion with an immobile fraction model is the best fit. Only the Pvr 
RNAi treatment results in a statistically significant change in the diffusion of the high-
ligand-affinity integrin. In this case, integrin diffusion is less constrained, as revealed 
by a faster diffusion coefficient at longer analysis times. For the wild-type integrin, 
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Pvr RNAi was the only treatment that did not result in a less constrained integrin 
diffusion. For both wild-type and high-ligand-affinity integrins, Notch RNAi results in 
the same 4 % increase in the integrin mobile fraction. Statistically similar lipid 
diffusion parameters were measured in the wild-type and high-ligand-affinity integrin-
expressing cells (data not shown). The histogram of Eapp has a larger population 
below the ~0.2 range for the high-ligand-affinity integrin compared to the wild-type 
integrin, but the high-ligand-affinity integrin does not have an appreciable population 
with values >0.2 at endogenous membrane protein concentrations (Figure 2.5b). 
After EGFR, Pvr, or Notch RNAi, the energy transfer histograms exhibit a statistically 
significant increase, although it should be noted that the manner and magnitude of 
this increase are not consistent for all three treatments. Previously, the high-ligand-
affinity integrin showed a 300 % increase in integrin clustering after reducing the 
membrane cholesterol concentration [35], which is consistent with an increase in 
energy transfer after EGFR, Pvr, or Notch RNAi for this integrin. Recall that the 
opposite effect, a decrease in energy transfer, was measured for the wild-type 
integrin after cholesterol depletion, Notch, EGFR, or Pvr RNAi. Combining these 
data strongly suggests that reducing the concentrations of EGFR, Pvr, or Notch 
alters integrin clustering via a mechanism involving a disruption in cholesterol-
enriched nanodomains. Caveolin 1-containing lipid rafts have been shown to play a 
role in coupling integrin, Notch, and EGFR signaling pathways [18]. Previous 
diffusion measurements using single-particle tracking have shown that proteins 
present in lipid nanodomains exhibit a 2- to 5-fold reduction in their mobility owing to 
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the high viscosity within these domains [46, 47]. Therefore, disrupting these domains 
could also explain some of the changes measured in integrin diffusion properties. 
 
2.5 CONCLUSIONS 
EGFR, Pvr, and Notch play a direct or indirect role in integrin clustering and 
diffusion, as elucidated using a combination of fluorescence microscopy and RNAi. 
While uniform changes in integrin clustering were measured after EGFR, Pvr, or 
Notch RNAi (i.e., a decrease in clustering for wild-type integrin and an increase in 
clustering for high-ligand- affinity integrin), differential changes in integrin diffusion 
were measured after the same RNAi treatments. Specifically, EGFR and Notch 
RNAi produced less constrained wild-type integrin diffusion, while Pvr RNAi 
produced less constrained diffusion in the high-ligand-affinity integrin. The 
differential partitioning of integrins into heterogeneous nanodomains or alterations to 
membrane nanodomain properties are the hypothesized mechanisms for how the 
other membrane proteins alter integrin clustering and diffusion. The methodology 
outlined herein will be suitable for unraveling the roles of numerous proteins in 
altering the clustering and diffusion of other membrane components. 
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Table 2.1 Diffusion parameters obtained from the constrained diffusion with an 
immobile fraction model before (No RNAi) and after the indicated RNAi treatment for 
wild-type integrin (αβ), high ligand affinity integrin (αβV409D) or lipid mimetic DiD.a 
αβ  
Integrin 
Mobile 
fraction 
D (1s) 
(x10-09cm2/s) 
D (50s) 
(x10-09cm2/s) 
No RNAi 0.67 ± 0.02 3.2 ± 0.2 0.6 ± 0.3 
EGFR  0.67 ± 0.01 4.4 ± 0.2 1.5 ± 0.5 
Pvr  0.66 ± 0.02 3.3 ± 0.2 0.8 ± 0.4 
Notch  0.71 ± 0.01 3.6 ± 0.1 2.8 ± 0.3 
    
αβ V409D  
Integrin 
   
No RNAi  0.67 ± 0.01 3.3 ± 0.1 1.0 ± 0.2 
EGFR  0.64 ± 0.02 3.7 ± 0.2 0.8 ± 0.4 
Pvr  0.66 ± 0.01 3.4 ± 0.1 1.5 ± 0.2 
Notch  0.71 ± 0.02 3.5 ± 0.2 0.9 ± 0.3 
    
Lipid    
No RNAi  0.94 ± 0.01 20.7 ± 0.4 14 ± 1 
EGFR  1.00 ± 0.01 19.2 ± 0.4 16 ± 2 
Pvr  0.99 ± 0.01 16.6 ± 0.6  
Notch  0.94 ± 0.01 31.0 ± 0.9 41 ± 6 
a Brownian diffusion assumed to be the best-fit model if the reduced chi2 was the same for time-
dependent diffusion with an immobile fraction and Brownian diffusion models. Only one diffusion 
coefficient is listed (i.e., time independent) if the best-fit model is Brownian diffusion.  
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Table 2.2 Target mRNA, target protein and target integrin expression levels before 
and after the indicated RNAi treatment for the cell line expressing wild-type (αβ) or 
high ligand affinity (αβV409D) integrin. 
A p-value below 0.05 shows statistical difference between control and each RNAi treatment. 
a No antibody available for this receptor in the studied cell line. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Relative 
Target 
mRNA 
Expression 
αβ 
Relative 
Target 
Protein 
Expression
αβ 
Relative 
Integrin 
Expression
αβ 
Relative 
Target 
mRNA 
Expressio 
αβ V409D 
Relative 
Target 
Protein 
Expression
αβ V409D 
Relative 
Integrin 
Expressio 
αβ V409D 
No 
RNAi 
 
1.00 1.00 1.00 1.00 1.00 1.00 
 
EGFR 
 
0.38 
(p<0.01) 
0.65 
(p=0.03) 
0.48 
(p<0.01) 
0.56 
(p<0.01) 
0.76 
(p<0.01) 
1.24 
(p=0.1) 
 
Pvr 
 
0.22        
(p<0.01) n/a
a 0.77 (p=0.01) 
0.19 
(p<0.01) n/a
a 
0.91 
(p=0.38) 
 
 
Notch 
 
0.51 
(p<0.01) 
0.79 
(p=0.03) 
0.80 
(p=0.06) 
0.26 
(p<0.01) 
0.76 
(p=0.04) 
1.23 
(p=0.05) 
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Figure 2.1 Schematic of the experimental approach used to measure the role of 
other membrane proteins in altering integrin diffusion and clustering. The simplified 
cell membrane shows a distribution of integrins and other membrane proteins within 
the bulk membrane (light gray) and membrane nanodomains (dark gray).  RNA 
interference (RNAi) was used to reduce the expression of a select membrane 
protein and alterations in integrin concentration, diffusion or clustering were 
subsequently measured. ICC: immunocytochemistry; FRET: fluorescence resonance 
energy transfer; FRAP: fluorescence recovery after photobleaching 
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Figure 2.2 Fluorescence images of a transformed Drosophila S2 cell expressing 
αPS2CβPS integrins and FRET reporter peptides. Images were obtained using the 
following filters: (a) donor YFP; (b) acceptor dsRED; and (c) FRET [1]. An example 
region of interest used to calculate FRET is shown in a (blue). An average 
background value from the white region of interest is subtracted from every pixel 
before calculating FRET using equation 1  
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Figure 2.3 Select integrin FRAP images from a series showing the recovery of 
fluorescence, where bleached and non-bleached regions of interest are shown in red 
and green circles, respectively. A background region of interest is shown in blue. a: 
before photobleaching; b: immediately after photobleaching, t = 0 seconds; c: t = 25 
seconds; d: t = 50 seconds 
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Figure 2.4 Normalized average fluorescence recovery after photobleaching (FRAP) 
curves obtained from at least ten replicate measurements (symbols, mean ± 
standard error) and fits from the best diffusion model (dotted lines) for (a) wild-type 
integrin (b) high ligand affinity integrin and (c) lipid before (black curves) and after 
the RNAi treatments for EGFR (gray curves), Pvr (red curves) and Notch (blue 
curves). The integrin FRAP curves were collected for a total of 90 seconds, only a 
portion of the data is shown for clarity. The inset tables show reduced chi2 values 
obtained from modeling the FRAP curves to: 1 Brownian diffusion; 2 constrained 
diffusion; 3 constrained diffusion with an immobile fraction models before (No RNAi) 
and after the indicated RNAi treatments  
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Figure 2.5 Histograms of all the FRET values (Eapp) at each pixel measured in cells 
expressing wild-type integrins and FRET reporter peptides (solid black), wild-type 
integrins and FRET control peptides (shaded gray) or high ligand affinity integrins 
and FRET reporter peptides (dotted black): (a) endogenous protein concentrations; 
(b) after EGFR RNAi; (c) after Notch RNAi; (d) after Pvr RNAi; and (e) the statistical 
results comparing the no RNAi histogram to each RNAi treatment histogram. Each 
histogram was collected from a minimum of 50 cells 
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CHAPTER 3 
SINGLE PARTICLE TRACKING WITH STEROL MODULATION 
REVEALS THE CHOLESTEROL-MEDIATED DIFFUSION 
PROPERTIES OF INTEGRIN RECEPTORS 
Neha Arora, Aleem Syed, Suzanne Sander and Emily A. Smith 
3.1 ABSTRACT 
A combination of sterol modulation with cyclodextrins plus fluorescence microscopy 
revealed a biophysical mechanism behind cholesterol's influence on the diffusion of 
a ubiquitous class of receptors called integrins. Single particle tracking (SPT) 
measured heterogeneous diffusion of ligand-bound integrins, and fluorescence 
recovery after photobleaching (FRAP) measured the ensemble changes in integrin 
diffusion. A 25 ± 1% reduction of membrane cholesterol concentration resulted in 
three significant changes to the diffusion of ligand-bound αPS2CβPS integrins as 
measured by SPT.  There was a 23% increase in ligand-bound mobile integrins; 
there was a statistically significant increase in the average diffusion coefficient inside 
the confined domains and histograms of confined integrin trajectories showed an 
increased frequency in the range of 0.01-1 µm2/s and a decreased frequency in the 
0.1-1 µm2/s range. No statistical change was measured in the duration of 
confinement or the size of confined domains. Restoring the cholesterol-depleted 
cells with exogenous cholesterol or exogenous epicholesterol resulted in a similar 
histogram of diffusion coefficients as measured prior to cholesterol depletion. 
Epicholesterol differs from cholesterol in the orientation of a single hydroxyl group. 
The ability of epicholesterol to substitute for cholesterol suggests a biophysical 
mechanism for cholesterol’s effect on integrin diffusion. 
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3.2  INTRODUCTION 
As a major lipid component of the cell membrane, cholesterol plays a crucial 
role in membrane organization, dynamics and function [1]. Over the past several 
years it has been revealed that cholesterol is involved in the organization of the cell 
membrane [2-7]. Lipid nanodomains contain heterogeneous concentrations of 
cholesterol and glycosphingolipids as compared to the bulk membrane. These 
nanodomains have been implicated as platforms for the co-localization of many 
membrane proteins necessary for transmembrane signaling [2, 8].  
Alterations in cell membrane cholesterol concentration are known to affect the 
function of a number of receptor proteins [9]. In this regard, the most extensively 
studied receptor family is G-protein coupled receptors (GPCRs) [10]. Depletion of 
cholesterol from the cell membrane reduces the ligand-binding affinity of several 
GPCRs including oxytocin, cholecystokinin, galanin and serotonin [10-13]. An 
increase in the amount of membrane cholesterol favors the inactive conformation of 
the photoreceptor rhodopsin [10]. Cholesterol is also necessary for the proper 
functioning of the nicotinic acetylcholine receptors [14].  
The present study explores the mechanism and heterogeneity of cholesterol-
mediated diffusion of an important class of membrane protein receptors called 
integrins. Integrins are known to be involved in numerous fundamental cellular 
processes, including cell growth, survival, motility, adhesion and proliferation [15]. 
Cholesterol is known to modulate integrin function and clustering [16, 17]. A recent 
study revealed the influence of cholesterol on adhesion and signaling properties of 
αvβ3 and α5β1 integrins [18, 19]. Cholesterol has also been found to be essential for 
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the formation of a signaling protein complex comprising αvβ3 integrins [18]. Depleting 
cholesterol from the membrane led to the dissociation of this protein complex as 
revealed by the absence of co-immunoprecipitation of the proteins in the complex. In 
a study by Krauss et al., it was shown that integrin LFA-1 mediated cell adhesion 
was disrupted when the cholesterol content of the membrane was reduced [20]. 
Additionally, less integrin clustering was observed after 27% cholesterol depletion 
from the cell membrane [17]. Although it is evident that cholesterol plays an 
important role in modulating integrin function, details of the heterogeneous nature of 
and mechanism behind cholesterol-mediated integrin diffusion are not known. The 
diffusion of integrins is important to their function. Diffusion can affect the localization 
and clustering of integrins [21, 22]. An increase in cell adhesion is observed with an 
increase in integrin diffusion [12, 23]. Herein, cholesterol-dependent integrin 
diffusion properties are discussed and a mechanism of cholesterol-mediated 
changes in integrin function is proposed.  
One strategy to study the influence of cholesterol on receptor diffusion 
involves measuring integrin diffusion properties at native, reduced and restored 
cholesterol or epicholesterol concentrations [24]. Epicholesterol differs from 
cholesterol only in the orientation of the hydroxyl group at position 3 (Figure 3.1 (a) 
and (b)). Physical properties of the cell membrane, including membrane fluidity and 
lipid domain formation, are unaffected by the substitution of cholesterol with 
epicholesterol in the membrane [25]. However, the difference in the structure of the 
two isomers can result in remarkable differences in their specific biochemical roles 
[26, 27]. Thus, the specificity of cholesterol in altering integrin diffusion and the 
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mechanism behind cholesterol-mediated regulation of integrin diffusion can be 
determined by modulating the membrane sterol composition. Heterogeneous 
diffusion of integrin receptors in the cell membrane was measured using single 
particle tracking (SPT) with ligand-coated quantum dots or fluorescence recovery 
after photobleaching (FRAP) for ensemble diffusion measurements. Cholesterol 
modulation was performed using methyl-β-cyclodextrin (MβCD). Cyclodextrins have 
been used extensively to modulate the cholesterol levels in cells due to their ability 
to act as efficient donors and acceptors of sterol [28]. Sterol and integrin 
quantification were performed with liquid chromatography-mass spectrometry using 
atmospheric pressure chemical ionization (LC/APCI-MS) and Western blotting, 
respectively. 
 
3.3 MATERIALS METHODS 
3.3.1 Cell Culture 
 Drosophila S2 cells used in this study were transformed to express wild-type 
αPS2CβPS integrins under the regulation of the heat shock promoter. For FRAP 
experiments, αPS2CβPS integrins were tagged with a Venus fluorescent protein in 
the serine-rich loop, which has previously been used to insert epitope tags without 
any change to measureable function [29]. For Western blotting, the hemagglutinin 
epitope was added to the extracellular region of the α subunit. The cells were 
cultured as previously published [30]. To induce integrin expression, cells were 
placed in a 36 °C water bath for 30 min and allowed to recover for 3 h at 22 °C 
before taking measurements.  
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3.3.2 Preparation of ligand-coated quantum dots and labeling 
 Quantum dots (QDs) measuring 16 nm in diameter were obtained from Life 
Technologies (Carlsbad, CA, USA). The conjugation of positively charged QDs with 
net-negatively charged RBB-tiggrin ligand was achieved as described previously 
[31]. For labeling the integrins with ligand-conjugated quantum dots (hereafter QD-
RBB tiggrin), cells that had been heat shocked and allowed to recover for 3 h were 
centrifuged at approximately 600 × g for 3 min and the resulting pellet was 
resuspended in serum-free medium to adjust the final concentration to 5 × 105 
cells/mL. Cells were then spread on RBB-tiggrin coated glass slides for 1 h at room 
temperature [30]. Media was removed and cells were incubated with a 50 µL 
suspension of 0.1 nM QD-RBB tiggrin for 5 min.  Finally, the cells were rinsed with 
BES Tyrodes buffer for imaging. The binding specificity of QD-RBB tiggrin to 
integrins was examined using untransformed S2 cells that have no detectable 
endogenous integrin expression. Nonspecific binding was negligible, approximately 
1 %. 
 
3.3.3 Imaging 
 Imaging of the cells was performed by conventional fluorescence microscopy 
at room temperature. A Nikon Eclipse TE2000U inverted microscope (Melville, NY, 
USA) was equipped with an oil-immersion objective (100×, NA=1.49) and specific 
filter sets were used for excitation and emission of QDs and YFP for SPT and FRAP 
experiments respectively.  A mercury lamp was used for illumination and all images 
were captured using a PhotonMAX 512 EMCCD camera (Princeton Instrument, 
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Trenton, NJ, USA).  Winview software (Photometrics, Tucson, AZ, USA) allowed the 
recording of images as a function of time. All analyses were completed within 1 h 
after adding BES buffer. 
 
3.3.4 Single Particle Tracking (SPT)  
Images were recorded at 25 frames/second for a total of 30 seconds. Images 
were processed using Image J version 1.45 s and the ImageJ plugin Particle Tracker 
version 1.2 and trajectories from at least 90 quantum dots were generated as 
described previously [31]. Single quantum dots were identified by their on-off 
blinking behavior and only trajectories generated from single quantum dots were 
analyzed. Trajectories consisting of less than 100 frames were excluded from the 
analysis.  
 Trajectory analysis was performed using a recently developed Matlab-
implemented application with a graphical user interface that is based on a well-
established algorithm [32]. Trajectories of single quantum dots were analyzed for the 
presence of confinement zones. Confinement zones are regions where a diffusing 
particle remains for a time duration considerably longer than a Brownian diffusant 
would stay in an equally sized region. A confinement index, L, was calculated for 
each trajectory as described previously [32]. Trajectories were categorized into two 
different modes of diffusion: Brownian diffusion with no confined zones, and confined 
diffusion with one or more confined zones. An L > 3.16 for a duration > 1.1 s had a 
likelihood of 99.93+ % to reflect confined diffusion.  For each trajectory, 
characteristic and instantaneous diffusion coefficients were calculated by analyzing 
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the plot of mean square displacement (MSD) vs time according to Michalet et al. 
[33]. Trajectories with confined diffusion were further analyzed to determine the size 
of the confinement, the duration of the confinement and the diffusion coefficients 
inside the confined zones.  
 
3.3.5 Fluorescence recovery after photobleaching (FRAP) 
FRAP experiments were carried out on S2 cells transformed to express 
integrins attached with venus fluorescent proteins. An argon ion laser (488 nm line) 
was used for photobleaching and the recovery of fluorescence was monitored using 
mercury lamp excitation. Images were collected using a 500/20 nm excitation and a 
535/30 nm emission filter. The exposure time for each image was 0.35 s, and 
images were collected every 0.40 s.  Fluorescence images were analyzed as 
previously described [24] by fitting them to three models based on Eq. 1 [25] with an 
in-house-developed Igor Pro macro (version 4.0). 
               (1)
 
F0 is the initial fluorescence intensity after photobleaching; Fin is the fluorescence 
intensity at an infinite recovery time; τ is the time for 50% of the fluorescence to 
recovery, and α is the time exponent providing a measure of how much diffusion is 
confined. The most appropriate model set was determined by comparing the 
reduced chi2 values obtained for each model. The best fit model generates a 
reduced chi2 value of 1. Values obtained from the fit of the fluorescence recovery 
curve were used to calculate the diffusion coefficient, D(t) (Eq. 2). 
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where ω is the radius of the focused Gaussian laser beam and β is the photobleach 
depth [26]. All diffusion parameters are listed in supplementary information Table 
3.2. Diffusion parameters for the best-fit model of integrins and lipids are listed in 
Tables 3.2 and 3.3. Error bars on all reported FRAP fit parameters represent 
uncertainty at the 95% confidence level. Most of the curves were best fit to a model 
for time-dependent diffusion with an immobile fraction. 
 
3.3.6 Western Blot Analysis  
 After the heat shock and 3 h recovery, integrin expressing cells were subjected 
to cholesterol depletion, restoration, or substitution as described above. Cells were 
washed twice with cold 1 × PBS, pH 6.5 (0.13 M NaCl, 7 mM Na2HPO4, 3 mM 
NaH2PO4) at 4 °C and lysed using RIPA buffer (150 mM sodium chloride, 1.0% NP-
40 detergent, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris, pH 8.0) 
containing Halt™ Protease Inhibitor Cocktail (Thermo Scientific, Rockford, IL). 
Proteins were chloroform/methanol precipitated, redissolved in sodium dodecyl 
sulfate (SDS) buffer (4% SDS, 50 mM Tris, 5 mM EDTA, pH 7.4) and separated by 
SDS polyacrylamide gel electrophoresis (PAGE). After electrophoresis, the proteins 
were electro-transferred to Immun-Blot® LF PVDF membrane (Bio-Rad, Hercules, 
CA) according to standard protocols [34, 35]. Following protein transfer, the 
membrane was probed following the manufacturer's protocol (Bio-Rad). Antibodies 
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used for blotting were: anti-HA rabbit polyclonal (primary, 1:1000, Invitrogen, 
Oregon) and Alexa Fluor 647-conjugated goat anti-rabbit IgG (secondary, 1:10,000, 
Invitrogen, Oregon). The antibody labeling was detected and analyzed by 
fluorescent scanning on a Typhoon9410 (GE Healthcare, Waukesha, WI). As a 
loading control, the membrane was stripped and reprobed with an antibody against 
the cytoplasmic protein actin (Santa Cruz Biotechnology, Santa Cruz, CA). The 
normalized intensity of the 180 kD/43 kD bands was measured in Image J version 
1.45 s. 
 
3.4 RESULTS AND DISCUSSION 
3.4.1 Modulation of cellular cholesterol concentration with methyl-β-
cyclodextrin 
  In this study, MβCD was used to alter the sterol content in S2 cells 
transformed to express αPS2CβPS integrins. The total cellular and membrane 
cholesterol concentrations as measured by liquid chromatography-mass 
spectrometry in untreated, cholesterol-depleted and cholesterol-restored cells are 
summarized in Figure 3.2. Membrane cholesterol is the most relevant fraction for 
this study since it can influence integrin diffusion in the cell membrane (Figure 3.2 
(a)).  Total cellular (intracellular plus membrane) cholesterol concentration was also 
measured to provide information about the efficacy of the sterol depletion and 
restoration (Figure 3.2 (b)). Total cellular cholesterol was depleted by 44% with 2.5 
mM MβCD treatment. The percent decrease in membrane cholesterol (25%) was 
lower than the measured decrease for total cellular cholesterol. This is consistent 
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with a previous study supporting the notion that the distribution of cholesterol into 
intracellular and cell membrane pools is affected by cholesterol depletion [17]. 
Similar cholesterol depletion levels were achieved using 5 mM MβCD, indicating 2.5 
mM MβCD is sufficient for subsequent experiments.  
 Exposing the previously cholesterol-depleted cells to 2.5 mM MβCD 
preloaded with cholesterol (MβCD:cholesterol) restores the total cellular and 
membrane cholesterol levels to 126% and 82% of the native levels, respectively. A 
complete restoration of membrane cholesterol was not achieved despite a higher 
total cellular cholesterol concentration. Similar to what was found with the depletion 
step, 5 mM MβCD:cholesterol produced statistically similar results as 2.5 mM 
MβCD:cholesterol, therefore, 2.5 mM MβCD:cholesterol was used for subsequent 
restoration experiments.  
 
3.4.2 Classification of integrin diffusion by SPT: Cholesterol depletion 
increases the integrin mobile fraction 
Integrin diffusion was analyzed for 90-100 trajectories and categorized as 
immobile, or mobile with Brownian or confined diffusion in each cell population: 
untreated, cholesterol-depleted and cholesterol-restored. A quantum dot, and 
therefore a trajectory, was considered to be immobile in a given region if the median 
of its instantaneous diffusion coefficient was below 0.001 µm2 /s. All mobile 
trajectories collected from the three cell populations are shown in Figure S3.2. The 
most obvious difference among the three cell populations is the varying number of 
mobile trajectories. In untreated cells with a native cholesterol concentration, 74% of 
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integrins were mobile with 36 mobile trajectories showing confined diffusion and 38 
mobile trajectories showing Brownian diffusion (Table 3.1). Immobile and confined 
trajectories may represent the population of integrins in confined membrane regions 
and/or interacting with confined cytoskeletal proteins.  
After cholesterol depletion, the integrin mobile fraction increased to 97% 
(Table 3.1), which may be expected if integrin immobilization is cholesterol 
dependent. There is a small increase in the number of trajectories exhibiting 
Brownian diffusion after cholesterol depletion; however, the increase in the mobile 
fraction is primarily associated with a larger number of integrins diffusing with 
confined zones. There isn’t a statistically significant change in the size of the 
confined zones nor does the average time integrins spend in the confined zones 
change after cholesterol depletion (Table 3.1 and Figure 3.3). Assuming immobile 
trajectories aren’t associated with confined domains, this suggests that more 
integrins partition into confined domains after cholesterol depletion.  
After cholesterol restoration (Table 3.1) the mobile integrin fraction decreased 
to 82% and the number of trajectories exhibiting confined diffusion decreased to 50. 
These values are higher than what was measured in the untreated cell population 
(i.e., 74% and 38). This may be the result of incomplete restoration of membrane 
cholesterol upon treatment with MβCD:cholesterol (Figure 3.2), the result of other 
changes that may occur in the membrane, for example other lipids may be affected 
by MβCD, or there may be a time dependence to the restoration of some diffusion 
properties. The percentage of particles exhibiting Brownian diffusion decreased to 
32. 
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In contrast to SPT, the ensemble FRAP measurements showed a 25% 
decrease in the mobile integrin fraction after cholesterol depletion (Table 3.2).  The 
mobile fraction was 0.90 after cholesterol restoration. We have previously reported 
differences between ensemble FRAP and SPT results for αPS2CβPS integrins 
under selected conditions [31]. The main reason for the difference is understood by 
considering each pool of integrin measured in the experiment. In FRAP, all ligand-
bound and ligand-unbound integrins within the probed membrane region of a few 
microns square contribute to the signal; whereas in SPT only integrin bound to 
ligand (in this case on the quantum dot) is measured. Arnold et al. have shown that 
300 ligand-bound integrins per µm2 is the minimum density required for cells to 
spread [36]; whereas if only size constraints are considered, a maximum of several 
thousand integrins can pack in the same area. It could be argued that the quantum 
dot affects the diffusion measurements; yet the same diffusion properties have been 
previously measured by FRAP and SPT under some experimental conditions [31]. 
The diffusion of a receptor within the membrane is primarily influenced by the higher 
viscosity of the membrane compared to their surrounding medium. This means that 
the attached probe (quantum dot or the Venus fluorescent protein) in the 
extracellular space has limited influence on the diffusion coefficient [37].  Another 
important fact is that the size of the quantum dots used in this study is comparable to 
that of integrin, therefore a single quantum dot should bind a single integrin, and 
integrin clusters are not being formed as a result of multivalent binding to a quantum 
dot. 
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3.4.3 Cholesterol depletion influences integrin diffusion coefficient in the 
confined zones 
Plots of confinement index and instantaneous diffusion coefficient for a 
trajectory exhibiting only Brownian diffusion and a trajectory with one confined zone 
(red circle) are shown in Figure 3.4.  In general, the instantaneous diffusion 
coefficient varies significantly at different times in the trajectory and confinement 
zones are associated with lower instantaneous diffusion coefficient values. For 
trajectories with confined zones, average diffusion coefficients were calculated 
inside and outside the confinement zones (Table 3.1). After cholesterol depletion, 
the diffusion coefficient significantly increased in the confined zones and there was 
no significant change in the diffusion coefficient outside the confinement zones. After 
cholesterol restoration, the diffusion coefficient within the confined zones returns to 
the value measured for untreated cells. This indicates that integrin diffusion in the 
confined zones is cholesterol-dependent; whereas outside the zones the diffusion is 
cholesterol-independent as measured by SPT.  
To probe for individual integrin populations affected by cholesterol depletion, 
histograms for the diffusion coefficients inside and outside the confined zones were 
plotted (Figure 3.5). After cholesterol depletion, there are two significant changes 
observed in the distribution of diffusion coefficient inside the confined domains when 
considering differences of 5% or more (Figure 3.5A). There is a 30% decrease in the 
integrin population with a diffusion coefficient in the range of 0.01-0.1 µm2/s, and a 
9% increase in the population in the range 0.1-1 µm2/s after cholesterol depletion. In 
contrast, the distribution of diffusion coefficient outside the domains showed a 9% 
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decrease in the integrin population with a diffusion coefficient in the range of 0.001-
0.01 µm2/s, and a 9% increase in the population in the range 0.1-1 µm2/s (Figure 
3.5B). To confirm that the resultant changes in the histogram were cholesterol 
specific, cholesterol was restored in a previously cholesterol-depleted cell population 
prior to measuring integrin diffusion. After cholesterol restoration, the changes that 
were caused by cholesterol depletion were restored and a similar histogram of 
diffusion coefficients was measured.  
There is a statistically significant increase in the ensemble integrin diffusion 
coefficient measured by FRAP after cholesterol depletion (Table 3.1). The diffusion 
coefficient measured by FRAP after cholesterol restoration decreases to a value 
near what was measured at native cholesterol concentrations, indicating the 
increase in the diffusion coefficient after cholesterol depletion is cholesterol-
mediated and not the result of another change to the membrane composition. 
 
3.4.4 Mechanism for cholesterol-mediated changes to integrin diffusion 
 The measured differences in integrin diffusion properties after cholesterol 
depletion could be due to: (i) cholesterol affecting the physical properties of the 
membrane such as its fluidity or (ii) cholesterol interacting with integrin or another 
membrane component that influences integrin diffusion. It is also possible that a 
combination of both occur simultaneously. Any direct interaction with cholesterol is 
likely to be stereoselective; whereas cholesterol’s influence on the biophysical 
properties of the membrane are not. To elucidate the mechanism by which 
cholesterol affects integrin diffusion, cholesterol in the cell membrane was partially 
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substituted with its stereoisomer epicholesterol. If similar diffusion properties are 
measured after cholesterol restoration or partial epicholesterol substitution, it can be 
concluded that cholesterol regulates integrin diffusion by changing the physical 
properties of the membrane, otherwise specific biochemical interactions may also be 
involved.  
MβCD saturated with epicholesterol (MβCD:epicholesterol) was used to 
partially substitute cholesterol with epicholesterol in the cell membrane. The 
treatment resulted in a 47% substitution of cholesterol by epicholesterol in the cell 
membrane (Figure 3.2), and a nearly ideal restoration of membrane sterol 
concentration. This is consistent with previous studies that showed ~50% 
substitution of epicholesterol in the cell membrane irrespective of the concentration 
of MβCD used [26, 38, 39]. The total cellular sterol concentration was not restored 
after MβCD:epicholesterol treatment (Figure 3.2 (b)), which may be the result of 
altered membrane internalization. In order to measure whether sterol modulation 
affected integrin concentration, Western Blot analyses were performed using cells 
with native, depleted, restored or substituted sterol content (Figure 3.6). There was 
no statistically significant change in integrin concentration among any of the cell 
populations, indicating measured differences in diffusion properties are not the result 
of changes in integrin concentration. 
 Epicholesterol generated statistically similar integrin diffusion properties as 
were measured after cholesterol restoration (Table 3.1, Figure 3.5).  As measured 
by SPT there was no statistically significant difference in the average diffusion 
coefficient of mobile integrins inside and outside the confined domains after 
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cholesterol restoration and partial epicholesterol substitution (Table 3.2). The 
ensemble diffusion coefficient measured by FRAP were also statistically similar 
(Table 3.2). Finally, the fraction of mobile integrins exhibiting confined diffusion is 
also similar after cholesterol restoration and partial epicholesterol substitution, and 
there is a 82% mobile fraction in both cell populations (Table 3.1)   
 In summary, integrins in the cell membrane exhibit a biophysical-dependent 
change in integrin diffusion upon cholesterol-depletion. Partial substituting of 
cholesterol with epicholesterol restored the depletion-induced changes to integrin 
diffusion. Epicholesterol is known to mimic the effects of cholesterol on membrane 
physical properties. Hence, the changes to integrin diffusion that are measured after 
cholesterol depletion are likely due to the overall changes in the membrane and not 
a result of specific biochemical interactions of cholesterol involving the β-hydroxy 
group. 
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Table 3.1 Diffusion parameters obtained from SPT analysis of 100 integrin 
trajectories. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 a calculated from the total 100 analyzed trajectories for each cell population. 
b Results are averaged over 90-100 trajectories containing at least one confinement zone. 
b p-values were obtained from Welch’s t-test 
 
 
 
 
 
 
 No 
treatment 
Cholesterol 
depletion 
Cholesterol 
restoration 
Partial 
epicholesterol 
substitution 
Mobile trajectories 
(%) a 74 97 82 82 
Brownian Trajectories 
Trajectories with 
Brownian diffusion 
(#)  
36 40 32 32 
Diffusion coefficient 
(µm2/sec)  b 0.2  ± 0.3 
0.2  ± 0.3 
(p=0.9) 
0.1 ± 0.1 
(p=0.1) 
0.1 ± 0.1 
(p=0.3) 
Confined trajectories 
Trajectories with  
confined diffusion 
(#)   
38 57 50 51 
Diffusion coefficient 
inside the confined 
zones (µm2/sec)b 
0.01 ± 0.03 0.03 ±  0.06 (p=0.03*) 
0.01 ±  0.03 
(p=0.5) 
0.02 ±  0.04 
(p=0.3) 
Diffusion coefficient 
outside the 
confined zones 
(µm2/sec)b 
0.1 ± 0.3 0.08 ±  0.14 (p=0.6) 
0.07 ± 0.13 
(p=0.4) 
0.05 ± 0.13 
(p=0.3) 
Diameter of 
confined 
 zones (µm) b 
0.2 ± 0.2 0.4  ± 0.4 (p=0.09) 
0.2 ± 0.2 
(p=0.8) 
0.2 ± 0.2 
(p=0.5) 
Duration of 
confined  
zones (s) b 
2.6 ± 1.8 2.7 ±  2.8 (p=0.9) 
2.2 ±  1.2 
(p=0.09) 
2.4 ± 1.1 
(p=0.3) 
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Table 3.2 Integrin mobile fractions and diffusion coefficients as measured by FRAP    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Treatments Mobile Fraction 
Diffusion 
Coefficient 
at 1s 
(µm2/s) 
Diffusion 
Coefficient 
at 50s 
(µm2/s ) 
No treatment 0.77 ± 0.02 0.84 ± 0.07 0.50 ± 0.05 
Cholesterol depletion 0.58 ± 0.02 1.8 ± 0.1 2.5 ± 0.5 
Cholesterol restoration 0.90 ± 0.05 0.8  ± 0.1 0.26 ± 0.04 
Partial epicholesterol 
substitution 0.74 ± 0.03 0.9 ± 0.1 0.31 ± 0.04 
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Figure 3.1 Structure of (a) cholesterol and its stereoisomer (b) epicholesterol. (c) 
The chromatogram of a standard mixture of the two isomers and stigmasterol 
(internal standard) separated and detected by LC/APCI-MS. (d) The chromatogram 
of the lipids extracted from untreated cells (gray) and partial epicholesterol-
substituted cells (black). Peak 1: epicholesterol, Peak 2: cholesterol, Peak 3: 
stigmasterol  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(a) 
 
(b) 
(c) 
 
(d) 
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Figure 3.2  (a) Membrane and (b) total cellular cholesterol concentration as 
measured by LC/APCI-MS in S2 cells expressing αPS2CβPS integrins in untreated 
cells, cells exposed to 2.5 or 5 mM MβCD to deplete cholesterol concentrations 
(depletion), in cells first depleted of cholesterol using empty 2.5 or 5 mM MβCD and 
then exposed to 2.5 or 5 mM MβCD:cholesterol (restoration) and in cells first 
depleted of cholesterol using empty 2.5 or 5 mM MβCD and then exposed to 2.5 or 5 
mM MβCD:epicholesterol (substitution).  The dark gray bars represent cholesterol 
and the light gray bars represent epicholesterol. Error bars represent one standard 
deviation from duplicate measurements. * p-value < 0.05 compared to the no 
treatment data. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(a) 
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Figure 3.3 Frequency histograms of the size (a-d) and duration (e-h) of confined 
zones. The results were normalized to the total number of mobile confined zones. 
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Figure 3.4 Plots showing  (a) a trajectory with a single confined zone depicted by a 
red circle (b) a Brownian trajectory with no confined zones. Right panel C-D shows 
instantaneous diffusion coefficient and confinement index plots. Dashed blue line 
indicates the critical threshold value of confinement index, L. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
16 
17 
18 
19 
11 12 13 14 15 
Y 
(µ
m
) 
X (µm) 
0"
0.2"
0.4"
0.6"
0.8"
1"
0"
10"
20"
30"
40"
50"
0" 5" 10" 15"
D
iff
us
io
n 
co
ef
fic
ie
nt
, D
 
C
on
fin
em
en
t i
nd
ex
, L
 
Confinement index Diffusion coefficient 
16.5 
17.5 
18.5 
30 30.5 31 
Y 
(µ
m
) 
X (µm) 
0"
0.05"
0.1"
0.15"
0.2"
0"
1"
2"
3"
4"
5"
0" 2" 4" 6" 8" 10"
D
iff
us
io
n 
co
ef
fic
ie
nt
, D
 
C
on
fin
em
en
t i
nd
ex
, L
 
Time"(s)"
A"
B"
C"
D"
  
 
69 
 
Figure 3.5 Histograms of diffusion coefficients (A) inside and (B) outside the 
confined zone measured for each confined integrin trajectory in: untreated cells, 
cholesterol-depleted cells, cholesterol-restored cells, and partial epicholesterol-
substituted cells. Histograms were normalized with respect to the total number of 
trajectories in each data set; the number of mobile trajectories in each data set are 
shown in Table 3.1.  
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Figure 3.6 Western blot of the HA-tagged αPS2 integrin subunit. The αPS2 subunit 
has been shown to produce two bands at 180 kD and 165 kD (Gotwals et al., 1994). 
1: no treatment, 2: 2.5 mM MβCD (depletion), 3: 5 mM MβCD (depletion), 4: 2.5 mM 
MβCD followed by 2.5 mM MβCD:cholesterol (restoration) and 5: 5 mM MβCD 
followed by 5 mM MβCD:cholesterol (restoration), 6: 2.5 mM MβCD followed by 2.5 
mM MβCD:epicholesterol (substitution) and 7: 5 mM MβCD followed by 5 mM 
MβCD:epicholesterol (substitution). Actin (43 kD) was used as a loading control. 
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SUPPORTING INFORMATION FOR CHAPTER 3 
Supplemental Experimental Methods 
Cholesterol depletion, restoration and substitution. After the heat shock and 3 h incubation, 
the cell suspension was centrifuged at approximately 600 × g for 3 min and the pellet was 
resuspended in serum-free M3 medium containing 2.5 mM or 5mM MβCD (Sigma-Aldrich, 
St. Louis, MO) solution for 30 min at 22 °C to deplete cholesterol (Dibya et al., 2010).    
For cholesterol restoration, cholesterol-depleted cells were incubated with MβCD 
solution saturated with cholesterol (MβCD:cholesterol, molar ratio of 8:1) for 30 min at 22 °C 
that was prepared as described previously (Ge et al., 2010). Briefly, a small volume of 
cholesterol stock solution in chloroform was added to a glass vial and dried under a stream 
of nitrogen. The dried samples were then resuspended in 2.5 mM MβCD or 5mM MβCD, 
vortexed and sonicated to allow mixing, and incubated overnight with shaking at 200 rpm 
and 37 °C. The solution was filtered using a 0.2 µm filter immediately prior to use.  
To substitute cholesterol with epicholesterol, cholesterol-depleted cells were 
exposed to a saturated MβCD:epicholesterol solution for 30 min at 22 °C 
MβCD:epicholesterol was prepared using a similar protocol as used to prepare 
MβCD:cholesterol. Before lipid extraction, diffusion measurements or Western blot analysis, 
the cells were washed in serum-free medium to remove cyclodextrin. There were no 
measurable phenotype changes in the cells after any of the above-mentioned treatments. 
 
Extraction of lipids and LC/APCI-MS quantification of cholesterol and epicholesterol. After 
the heat shock and 3 h recovery, membrane and total cellular lipids were extracted as 
described previously (Dibya et al., 2010, Bezrukov et al., 2009) with the following change: 
the lipids were resuspended in methylene chloride for subsequent LC/APCI-MS 
measurements. 
Cholesterol and epicholesterol were quantified using an Agilent 6540 Ultra-High-
Definition (UHD) Accurate-Mass Quadrupole Time-of-Flight (Q-TOF) liquid chromatography 
mass spectrometry (LC-MS) system. Analyses were performed on Agilent XDB C18, 4.6 x 
150 mm, 1.8 µm column coupled with Agilent QTOF 6540 mass spectrometer equipped with 
APCI ion source. A mixture of methanol and water (100:0.5 v/v) at 1 ml/min flow rate was 
used as a mobile phase. The sample injection volume was 1 µL. All data were acquired in 
the positive ion mode. Commercial standards of cholesterol (Sigma, St. Louis, MO) and 
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epicholesterol (Stereloids, Newport, RI) were used to assign the peaks in the 
chromatograms and stigmasterol was used as an internal standard (figure 1 (c)). The 
measured resolution between the cholesterol and epicholesterol peaks was 1.2 for both the 
standard solutions and the lipid extract from the cells (figure 1 (c) and (d)). For quantification 
purposes, an external calibration curve was set up every day. Peaks were extracted and 
integrated using Agilent Masshunter software. The m/z values of 369.35 and 383.34 were 
used for quantification of both cholesterol and epicholesterol. All measurements were 
duplicated. 
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Figure S1. Average fluorescence recovery after photobleaching (FRAP) curves from 10 
replicate measurements (circles) of S2 cells expressing αPS2CβPS-Venus integrins (blue) 
at native cholesterol concentration; (black) reduced cholesterol concentration;(green) 
restored cholesterol concentration;(red) restored epicholesterol concentration. The data are 
fit (solid lines following the same color scheme previously described) to a model for time-
dependent diffusion with an immobile fraction. Curves have been normalized to the pre-
photobleach intensity. 
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 Figure S2. Trajectories of all mobile integrins obtained from SPT measurements showing 
diffusion of αPS2βPS integrins in: (a) untreated cells, (b) cholesterol-depleted cells, (c) 
cholesterol-restored cells, (d) partial epicholesterol-substituted cells. Trajectories have been 
distributed across the graph to prevent overlap. The absolute position of trajectories in the 
graph has no meaning since some trajectories were moved to prevent overlap, and the 
trajectories were collected from several cells with different shapes and locations on the 
microscope slide. Scale bar = 5µm. 
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CHAPTER 4 
THE ROLE OF POST-TRANSLATIONAL PALMITOYLATION 
IN ALTERING INTEGRIN DIFFUSION 
Neha Arora, Emily A. Smith 
4.1 ABSTRACT 
Proteins are covalently modified with a variety of lipids, including fatty acids, 
isoprenoids, and cholesterol. These lipid modifications play important roles in the 
membrane localization and function of proteins. Integrins, a family of signaling and 
adhesion proteins responsible for mediating fundamental cellular functions presents 
a good example of how post-translational modifications can modulate the structure 
and function of a protein.  Integrins are modified by the attachment of lipids, metal 
binding, or by tyrosine phosphorylation, all of which can modulate integrin structural 
and functional properties. Herein, the effects of integrin palmitoylation on the 
diffusion properties of this receptor are reported. Palmitoylation is a lipid modification 
that involves covalent attachment of palmitic acid on cysteine residues of proteins. 
Blocking the palmitoylation site altered the diffusion characteristics of integrins. 
Diffusion measurements from fluorescence recovery after photobleaching (FRAP) 
and single particle tracking (SPT) both indicated more mobile integrins in the 
absence of palmitoylation. Single particle tracking results showed a 9% and 5% 
higher integrin population with diffusion coefficients in the range of 0.01-0.1 µm2/s 
and 0.1-1 µm2/s, respectively, and a 13% lower integrin population with diffusion 
coefficients ranging from 0.001-0.01 µm2/s after the palmitoylation site was blocked. 
Additionally, the size of the confinement domains increased after blocking the 
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palmitoylation site. The role of palmitoylation in altering the diffusion of integrin 
receptors may be related to the partioning of integrins in the lipid nanodomains. 
Palmitoylation may be necessary for directing the integrins into these nanodomains. 
4.2 INTRODUCTION 
The integrin family of cell surface receptors is known to play a critical role in 
many fundamental cellular processes like cell adhesion, progression, growth, 
proliferation etc. [1]. Integrins mediate bidirectional signaling across the cell 
membrane [2]. This signaling occurs via ligand binding to integrins (outside-in 
signaling) and/or via binding of several cytosolic proteins (inside-out signaling). In 
general, efficiency of signaling depends on the concentration of involved proteins 
and also their correct localization in the signaling region [3]. Recent studies have 
highlighted the importance of post-translational modifications by specific lipids for 
localizing a protein into membranes and membrane domains [4]. Lipid attachment to 
proteins can thus greatly regulate cell signaling. 
Palmitoylation is the post-translational modification of cysteine residues in 
proteins with the 16-carbon saturated fatty acid palmitic acid [5]. It occurs on integral 
membrane proteins and membrane-associated proteins. Unlike other lipid post-
translational modifications such as myristoylation (attachment of myristic acid) and 
prenylation (attachment of isoprenoid lipids), palmitoylation is reversible [5]. Proteins 
can undergo multiple cycles of palmitoylation and depalmitoylation with the help of 
specific enzymes. There are diverse functional consequences of palmitoylation [5]. 
Some examples are as follows. Palmitoylation facilitates membrane association of 
modified proteins [6, 7]. It also facilitates selective targeting of proteins into 
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membrane subdomains [8-10]. Palmitoylated proteins are often involved in protein 
sorting and trafficking [11-13]. Palmitoylation also affects protein-protein interactions 
[14, 15].  
Figure 1 depicts the multiple sequence alignment of the transmembrane and 
cytoplasmic domains of the integrin α subunits of different species. Palmitoylation 
has been previously observed in α3, α6, α7 integrins [16]. In these integrins, a highly 
conserved membrane-proximal cysteine is palmitoylated. Additionally, palmitoylation 
has also been observed in the β4 tail of α6β4 integrin that promotes recruitment of 
these integrins into membrane nanodomains [16, 17]. In the present study, we study 
the effects of palmitoylation of the highly conserved cysteine on the diffusion of  
αPS2βPS integrins. By blocking the palmitoylation site using site-directed 
mutagenesis, we measured the consequences of palmitoylation on integrin diffusion. 
Fluorescence microscopy (fluorescence recovery after photobleaching and single 
particle tracking) was used to measure integrin diffusion properties.  
4.3 MATERIALS METHODS 
4.3.1 Cell Culture 
 Drosophila S2 cells were grown in Shields and Sang M3 insect media (M3, 
Sigma) supplemented with 10% fetal bovine serum (Irvine Scientific), 12.5 mM 
streptomycin, 36.5 mM penicillin, and 0.2 µM methotrexate (Fisher Scientific). Six 
stably transformed S2 cell lines were developed by expressing: (i) wild-type 
αPS2CβPS integrins, (ii) mutant αPS2C(C1368V)βPS integrins (iii) YFP-tagged wild-
type αPS2CβPS integrins, (iv) YFP-tagged mutant αPS2C(C1368V)βPS  integrins, 
(v) HA-tagged wild-type αPS2CβPS integrins or (vi) HA tagged mutant 
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αPS2C(C1368V)βPS, respectively. Cells were maintained in a 22°C incubator and 
were heat-shocked in a 36 °C water bath for 30 min to induce expression of integrins 
before conducting any further experiments.  
 
4.3.2 Instrumentation 
 A Nikon Eclipse TE2000U microscope (Melville, NY, USA) equipped with an 
oil immersion objective (100× 1.49 NA) was used for all microscopy experiments. A 
mercury lamp was used for imaging, and fluorescence images were collected using 
a PhotonMAX 512 EMCCD camera (Princeton Instrument, Trenton, NJ, USA). A 
filter set from Omega Optical (XF304-1, Brattleboro, VT, USA) was used for 
excitation (425/45 nm) and to collect the QD emission (605/20 nm). FRAP images 
were collected using a 500/20 nm excitation and a 535/30 nm emission filter. 
 
4.3.3 FRAP microscopy 
FRAP data were collected and analyzed according to previously published 
protocols (Sander et al., 2012, Mainali and Smith, 2013, Arora et al., 2012). Briefly, 
cells expressing YFP-tagged wild-type or mutant integrins were plated onto ligand-
coated glass slides. A series of images were acquired before and after 
photobleaching using mercury-lamp excitation on a timeframe of 75s. 
Photobleaching was accomplished with the 488-nm line of an argon ion laser. Data 
were analyzed using ImageJ version 1.38. Diffusion parameters were calculated 
according to the method of Feder et al. by fitting the recovery curves to three 
different models - Brownian, constrained and mixed diffusion [18].  A reduced chi2 
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value closest to 1 was used to indicate the best-fit model. Figure 4.2 shows the 
recovery curves and corresponding best fits for YFP-tagged wild-type and mutant 
integrins.  
 
4.3.4 Single particle tracking 
 Amine-derivatized polyethylene glycol (PEG) quantum dots (QDs) measuring 
16 nm in diameter and with emission maxima at 605 nm were used for SPT 
measurements (Life Technologies). QDs were conjugated with RBB-tiggrin ligand by 
mixing a ratio of 1 QD to 20 RBB-Tiggrin in 10 mM phosphate buffer, pH 8.5 for 2 h 
(Medintz et al. 2003; Delehanty et al. 2006; Xiao et al. 2010; Mattoussi et al. 2000). 
The ligand-coated QDs were sonicated for 2 h before diluting to the required 
concentration, and were then used within half an hour to limit the aggregation of 
QDs. Cells were then incubated with ligand-conjugated quantum dots [19].  
QD-labeled integrins were localized and tracked using the Particle Tracker 
Plugin of Image J. At least 90-100 trajectories were generated for each cell line. 
Data analysis was performed using a graphical user interface (GUI) in MATLAB to 
distinguish trajectories with Brownian diffusion, confined diffusion, to calculate 
diffusion coefficients, and to identify immobile integrin fractions [20]. 
 
4.4 RESULTS AND DISCUSSION 
4.4.1 Blocking the palmitoylation site increases integrin mobile fraction 
 Palmitoylation increases the affinity of proteins towards membranes 
nanodomains [21]. If αPS2βPS integrins associate with membrane nanodomains 
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due to palmitoylation, it is expected that the diffusion properties of wild-type integrins 
will differ from those of integrins lacking a palmitoylation site. There are two potential 
palmitoylated cysteins in the αPS2 integrin subunit - Cys1368 and Cys1352. It is 
hypothesized the Cys1368 is palmitoylated in αPS2βPS integrin based on the 
sequence homology with integrins experimentally shown to be palmitoylated at this 
site. To test that hypothesis, αPS2C(C1368V)βPS was constructed by mutating the 
Cys1368 to Val1368  in the α subunit. The diffusion properties of αPS2C(C1368V)βPS 
integrin were measured  and compared to the diffusion properties of wild-type 
αPS2βPS. Ensemble diffusion was measured using fluorescence recovery after 
photobleaching (FRAP), and the diffusion of single receptors was measured using 
single particle tracking (SPT).  
Table 4.2 lists the diffusion parameters obtained from FRAP microscopy. In 
cells expressing wild-type integrins, 60% of the integrins were mobile. In 
comparison, 93% of the integrin trajectories were mobile in cells expressing 
αPS2C(C1368V)βPS integrins. For single particle diffusion measurements, at least 
90 trajectories were analyzed in cells expressing wild-type αPS2CβPS integrins 
(containing the potential palmitoylation site) and cells expressing 
αPS2C(C1368V)βPS  integrins (lacking the potential palmitoylation site). Similar to 
the FRAP data, SPT data also shows more mobile integrin trajectories in the 
αPS2C(C1368V)βPS  cell line as compared to the wild-type cell line. The 
percentage of mobile αPS2C(C1368V)βPS  integrin trajectories was 92% as 
compared to 71% mobile wild-type integrin trajectories. Correlating both SPT and 
FRAP data, it can be concluded that any changes resulting from the removal of 
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Cys1368  increase the number of mobile integrins. The increased mobile fraction in the 
absence of Cys1368 does indicate the release of diffusion constraints possibly due to 
dissociation of integrins from membrane nanodomains. 
 
4.4.2 Blocking the palmitoylation site affects confinements to integrin 
diffusion 
Mobile trajectories generated from SPT experiments were characterized for 
the presence of confinement zones. Diffusion is Brownian when no confined zones 
exist.  Confined zones are defined as regions in the cell membrane where a particle 
stays for a time period that is longer than can be explained by Brownian diffusion. 
These confinements in the cell membrane may arise due to interactions of integrin 
with cytosolic proteins, or due to integrins residing in the constrained domains in the 
cell membrane (such as lipid nanodomains). A confinement index, L, was calculated 
for each trajectory. An L > 3.16 for a duration > 1.1 s had a likelihood of 99.93+ % to 
reflect confined diffusion.  When a trajectory showed regions of confinement, the 
trajectory was further analyzed to determine the size of confinement, time period of 
confinement and the diffusion coefficient inside and outside the confined region. 
These parameters were calculated and compared between wild-type and 
αPS2C(C1368V)βPS  integrins. Figure 4.3 shows plots of confinement index and 
diffusion coefficient for a trajectory exhibiting only Brownian diffusion and a trajectory 
with one confined zone (red circle). For wild-type integrins, periods of confined 
diffusion were identified in 53% of the trajectories (Table 4.1). These confinement 
zones averaged 0.26 µm in diameter and the confinements lasted for an average of 
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2.4 s. Interestingly, for αPS2C(C1368V)βPS  integrin, the periods of confinement 
were observed in 68% of the trajectories; 15% higher than that in wild-type 
αPS2CβPS  integrin. In mutant αPS2C(C1368V)βPS  integrin trajectories, the 
confinement zones measured 0.38 µm in diameter and the confinements lasted for 
an average of 2.6 s. Frequency histograms of confinement size and duration of 
confinement are shown in Figure 4.4. Comparison of data for αPS2C(C1368V)βPS  
and wild-type integrins indicated that only the size of the confinement domains were 
statistically different as indicated by a p-value less than 0.05 calculated with Welch’s 
t-test.  
 
4.4.3 Blocking the palmitoylation site affects integrin diffusion coefficient 
A characteristic diffusion coefficient was obtained for each trajectory. For 
trajectories exhibiting confined zones, diffusion coefficients were calculated both 
inside and outside the confined zones.  As shown in Table 4.2, the average diffusion 
coefficient of αPS2C(C1368V)βPS  integrins was statistically similar to the average 
diffusion coefficient of wild-type integrin trajectories. This indicates that 
palmitoylation does not affect the average diffusion coefficient of the ligand-bound 
integrin as measured in SPT. In contrast, FRAP results shown in Table 4.2 do 
indicate differences in the diffusion coefficient of wild type and αPS2C(C1368V)βPS  
integrins. As shown, the diffusion coefficient of αPS2C(C1368V)βPS  integrins that 
lack the palmitoylation site at longer analysis times is 35% higher than the average 
diffusion coefficient of wild-type integrins. On the contrary, diffusion coefficient at 
short analysis times for mutant αPS2C(C1368V)βPS  integrin is 25% lower than that 
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of wild-type integrin. FRAP measurements average the diffusion of a large number 
of receptors, including those bound to ligand and those that are unbound. It is 
hypothesized that the increase in the diffusion coefficient measured by FRAP is 
predominantly from ligand-unbound integrins, which could explain why there was no 
change in the average diffusion coefficient of ligand-bound integrin measured by 
SPT. 
Although, the average diffusion coefficient measured by SPT was similar in 
the two cell lines, histograms of the individual diffusion coefficients for each mobile 
integrin do show differences in selected diffusing populations. Figure 4.5 shows the 
histograms of diffusion coefficients inside and outside the confined domains. In both 
cell lines, although there is a three order of magnitude spread in integrin diffusion 
coefficients, the frequency of the integrin populations differ in the two cell lines. For 
example the αPS2C(C1368V)βPS integrins compared to wild-type integrin, have a 
9% and 5% higher population with diffusion coefficients in the range of 0.01-0.1 
µm2/s and 0.1-1 µm2/s, respectively. The population of integrins with diffusion 
coefficients ranging from 0.001-0.01 µm2/s is 13% lower in the αPS2C(C1368V)βPS  
integrin than in the wild-type integrin.  
 
4.5 CONCLUSIONS 
 Preliminary results revealed a role of palmitoylation in integrin diffusion. By 
blocking the palmitoylation site in αPS2CβPS integrins, we observed more mobile 
integrins. Both FRAP and SPT measured approximately 33% more mobile integrins 
in a single point mutant cell line, αPS2C(C1368V)βPS  where Cys1368 (the 
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palmitoylation site) was substituted with valine. Diffusion coefficient distribution as 
measured by SPT measured higher integrin population with diffusion coefficients in 
the range of 0.01-0.1 µm2/s and 0.1-1 µm2/s and lower integrin population in the 
range of 0.001-0.01 µm2/s in αPS2C(C1368V)βPS as compared to αPS2CβPS. In 
addition, larger confinement zones were measured after blocking the palmitoylation 
site. Additional work is required before definitive conclusions about the role of 
integrin palmitoylation on diffusion can be made.  It is hypothesized that the 
conserved Cys1368 is palmitoylated.  Experimentally this must be demonstrated. 
Several attempts were made to detect palmitoylation in αPS2CβPS integrins such as 
mass spectrometry and fatty acyl exchange chemistry. Future efforts involving the 
use of click chemistry to label and detect palmitoylated cysteine in αPS2CβPS 
should be pursued.  
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 Table 4.1 Diffusion parameters obtained from FRAP experiments. Data represent 
mean ± standard deviation from 10 replicate measurements. 
 D (1s) 
(µm2/s) 
D (50s) 
(µm2/s) 
Mobile 
fraction (%) 
Wild-type  αPS2CβPS  
integrins 
0.69 ± 0.02 0.140 ± 0.005 59.9  ± 0.7 
αPS2C(C1368V)βPS  
integrins 
0.52 ± 0.02 0.188 ± 0.007 93 ± 1 
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Table 4.2 Diffusion parameters obtained from SPT experiments 
 
  
 Wild-type 
αPS2CβPS 
integrins 
αPS2C(C1368V)βPS 
integrins 
Total Mobile trajectories (%) 71 92 
Trajectories with confined 
zones (#) 34 52 
Trajectories without 
confined zones (#) 29 24 
Average diffusion coefficient 
inside the confined domains 
(µm2/s) 
0.01 ± 0.02 0.03 ± 0.10 (p=0.1) 
Average diffusion coefficient 
outside the confined 
domains (µm2/s) 
0.05 ± 0.08 0.15 ± 0.36 (p=0.1) 
Average time in confined 
domains (s) 2.4 ± 0.1 
2.6 ± 1.6 
(p=0.5) 
Average diameter of the 
Confinement domains (µm) 0.26 ± 0.20 
0.38 ± 0.44 
(p=0.04*) 
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Figure 4.1 Integrin’s α-cytoplasmic and transmembrane sequence domain alignment 
of different species. The single-letter amino acid code is used. Species are: Ce, C. 
elegans; Dm, Drosophila; Hs, human. The amino acid sequence of Drosophila αPS2 
domain is shown in bold and the potential palmitoylation sites are shown in red.  
 
               Transmembrane domain      Cytoplasmic domain 
Hs alpha 8  IPLWVIILAILLGLLVLAILTLALWK CGFFDRARPPQEDMTDREQLTNDKTPEA               
Hs alpha 6  VPWWIILVAILAGILMLALLVFILWK CGFFKRSRYDDSVPRYHAVRIRKEEREI…  
Hs alpha 3  IELWLVLVAVGAGLLLLGLIILLLWK CGFFKRTRYYQIMPKYHAVRIREEERYP…  
Hs alpha E  HSLPIIIKGSVGGLLVLIVILVILFK CGFFKRKYQQLNLESIRKAQLKSENLLE…                                      
Dm PS2      VPLWVVVLAACAGALIFLLLVWLLYK CGFFNRNRPTDHSQERQPLRNGYHGDEH…                                         
Ce PAT2     LPWWLYLLAILIGLAILILLILLLWR CGFFKRNRPPTEHAELRADRQPNAQYAD…  
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Figure 4.2 Normalized average fluorescence recovery after photobleaching (FRAP) 
curves from 10 replicate measurements of S2 cells expressing venus tagged wild-
type αPS2CβPS (blue squares) and mutant αPS2C(C1368V)βPS integrins (red 
squares). The data are fit (solid lines) to a model for time-dependent diffusion with 
an immobile fraction (described in the text). 
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Figure 4.3 Plots showing  (a) a trajectory with a single confined zone depicted by a 
red circle (b) a Brownian trajectory with no confined zones. Right panel C-D shows 
instantaneous diffusion coefficient and confinement index plots. 
 
 
 
 
 
 
 
 
19.4 
19.8 
20.2 
20.6 
21 
22 22.4 22.8 23.2 23.6 
Y 
(µ
m
) 
0 
0.1 
0.2 
0.3 
0 
4 
8 
12 
16 
0 2 4 6 
Di
ffu
si
on
 c
oe
ffi
ci
en
t, 
µm
2 /s
 
Co
nﬁ
ne
m
nt
(in
de
x,
(L(
Confinement index Diffusion coefficient 
18 
20 
22 
24 
23 27 31 35 
Y 
(µ
m
) 
X (µm) 
0 
1 
2 
3 
4 
0 
1 
2 
3 
0 2 4 6 D
iff
us
io
n 
co
ef
fic
ie
nt
, µ
m
2 /s
 
Co
nﬁ
ne
m
nt
(in
de
x,
(L(
Time((s)(
  
 
91 
Figure 4.4 Frequency histograms of the size (A) and duration (B) of confined zones. 
The results were normalized to the total number of mobile confined zones. 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Figure 4.5 Histogram of diffusion coefficients of mobile particles (A) inside the 
confined zones and (B) outside the confined zones for wild-type αPS2CβPS  and 
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mutant αPS2C(C1368V)βPS  integrins. Histograms were normalized with respect to 
the total number of trajectories in each data set. 
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CHAPTER 5 
SUMMARY AND FUTURE WORK 
The work presented in this dissertation deepens our understanding of integrin 
diffusion and clustering in the cell membrane. Integrins are crucial for all cellular 
responses including cell adhesion, growth, survival and proliferation. Specifically, we 
have studied the interactions of integrins with other cellular components and how 
these interactions affect integrin clustering and diffusion properties that play key 
roles in integrin signaling.  
Chapter 2 studies the interactions of other membrane protein receptors with 
integrins. Using RNAi, the expression of select membrane proteins – Notch, EGFR 
and Pvr – was reduced and subsequent changes in integrin clustering and diffusion 
were measured by fluorescence microscopy. Clustering of wild-type integrins was 
decreased after the expression of Notch, EGFR and Pvr was reduced.  In contrast, 
high-ligand affinity integrin mutants showed an increase in clustering after the RNAi 
treatments for all three proteins. Diffusion results indicated that the presence of 
EGFR and Notch in the membrane constrains wild-type integrin diffusion and the 
presence of pvr constrains mutant integrin diffusion.  
In Chapter 3, the influence of cholesterol in affecting integrin lateral diffusion 
was studied. Cholesterol is known to intercalate in the lipid bilayer and helps to 
regulate membrane fluidity. An increase in integrin diffusion was measured after 
depleting ~50% cholesterol from the cell membrane. The mechanism behind 
cholesterol-mediated diffusion changes was investigated by partially substituting 
cholesterol in cells with epicholesterol, a stereoisomer of cholesterol that has same 
  
 
94 
physical properties as cholesterol but different chemical properties. Epicholesterol 
was unable to substitute for cholesterol in affecting integrin diffusion, which  
suggests the role of specific biochemical interactions involving 3-beta hydroxyl 
group. Whether direct interactions of cholesterol and integrins are involved or 
cholesterol interacts with another membrane component that may influence integrin 
diffusion, still needs to be explored.  
Chapter 4 describes the role of palmitoylation post-translational modification 
in affecting integrin diffusion. Palmitoylation is the covalent attachment of palmitic 
acid to the cysteine residues of proteins. In the absence of palmitoylation, there were 
significant changes in integrin diffusion. As an example, the integrin mobile fraction 
was increased by ~33% as measured by SPT and FRAP.   
 Future work could aim at characterizing other receptor families such as 
tetraspanins. The work can also be combined with super-resolution techniques like 
STED (stimulated emission depletion) that can provide sub-diffraction spatial 
resolution imaging. Furthermore, studies in mammalian cells can help to identify the 
details of the molecular function of integrins.   
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APPENDIX A 
NONINVASIVE MEASUREMENTS OF INTEGRIN 
MICROCLUSTERING UNDER ALTERED MEMBRANE 
CHOLESTEROL LEVELS 
A paper published in Biophysical Journal * 
Deepak Dibya, Neha Arora and Emily A. Smith 
ABSTRACT 
Reported herein is a method that can be used to study the role of cholesterol 
in the microclustering of a ubiquitous class of membrane receptors, termed integrins. 
Integrin microclustering was measured using a fluorescence resonance energy 
transfer assay that does not require direct attachment of fluorescent donors or 
acceptors onto the integrins, and thus minimizes unwanted perturbations to integrin 
clustering. Membrane cholesterol levels were reduced using methyl-β-cyclodextrin 
(mβCD), as confirmed by Amplex Red assays of total cellular lipid or plasma 
membrane lipid extract. Subsequent changes in integrin microclustering were 
measured in cells expressing wild-type (WT) or mutant integrins. Although less 
integrin microclustering was measured after 27% membrane cholesterol depletion in 
a cell line expressing WT integrins, there was no statistically significant change for  
cells expressing α-cytoplasmic integrin mutants after a 45% reduction in plasma  
 
*Reprinted with permission from The Journal of Analytical and Bioanalytical 
Chemistry Copyright © Springer 2012 
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membrane cholesterol, and a significant increase in clustering for cells expressing 
ligand-binding domain integrin mutants after a 57% decrease in membrane 
cholesterol. These results are explained by differences in WT and mutant integrin 
partitioning into lipid nanodomains. Restoration of original cholesterol levels was 
used to confirm that the measured changes in membrane properties were 
cholesterol-dependent. No correlations between lipid diffusion and integrin 
microclustering were measured by means of fluorescence recovery after 
photobleaching using a fluorescent lipid mimetic. Similar lipid diffusion coefficients 
were measured after cholesterol depletion, irrespective of the integrins being 
expressed.  
 
INTRODUCTION 
The survival, growth, proliferation, differentiation, and proper functioning of 
cells depend largely on a dynamic flow of information being maintained between the 
external and internal environments of the cell (1). To this end, cells employ receptors 
to relay information inside and outside of the cell (2–5). One of the mechanisms for 
signal transduction involves clustering of receptors within the cell membrane. 
Receptor clustering is involved in many vital processes, including immunological 
synapse formation, actin cytoskeleton regulation, and leukocyte regulation (6–8). 
Integrins comprise a class of receptors that are fundamentally important for many 
critical cellular functions (1,9). They are heterodimeric proteins composed of one α -
subunit noncovalently associated with one β-subunit (10). Both subunits contain a 
large extracellular domain and (by comparison) a short cytoplasmic domain. They 
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mediate signaling through the cytoplasm by binding to intracellular proteins, and 
through the extracellular matrix by binding to ligand (9). 
Fluorescence microscopy has been used to study the clustering of integrins 
within the cell membrane (11–13). Observing clusters in live cells that are smaller in 
size than the diffraction limit of light requires an imaging technique such as 
fluorescence resonance energy transfer (FRET) (14–16). In previous studies, 
integrin microclustering was measured using a FRET assay that did not require 
direct attachment of donor and acceptor FRET pairs to the integrins (17,18). Energy 
transfer was measured using transmembrane reporter peptides, which were 
generated by cloning the FRET donor or acceptor fluorescent protein to the 
transmembrane and cytoplasmic domain of the integrin β-subunit. Hereafter, these 
will be referred to as FRET reporters. The FRET reporters were coexpressed with 
integrins (17,18). When the integrins cluster in the membrane, so do the FRET 
reporters. This decreases the average separation distance between the donor and 
acceptor FRET reporters, and increases energy transfer. Conversely, when the 
separation distance between the integrins increases, less energy transfer is 
measured from the FRET reporters. The mechanism for the coclustering of integrins 
and FRET reporters is still under investigation. However, possible mechanisms can 
be deduced from evidence in the literature. The β -transmembrane and cytoplasmic 
domains contained in the FRET reporters were shown to be sufficient for clustering 
with integrins at muscle termini in vivo; additionally, it was reported that a chimera 
containing the transmembrane domain of an unrelated protein and the cytoplasmic 
domain of the β-subunit also localized to muscle termini, but the transmembrane and 
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cytoplasmic domains of the unrelated protein did not localize to muscle attachments 
(19). Finally, a peptide containing the transmembrane and cytoplasmic domains of 
the vertebrate β3 subunit was shown to form homotrimers by polyacrylamide gel 
electrophoresis in the absence of the extracellular domain (20). Control experiments 
showed that FRET reporters did not alter key integrin properties, and no energy 
transfer was measured when FRET reporters, but no integrins, were expressed in 
the membrane (17,18). 
Cholesterol intercalates between the fatty acyl chains of the lipid bilayer and 
is known to maintain membrane structure regulate membrane fluidity, and interact 
directly with some membrane proteins (21–25). Cholesterol is an important 
constituent in membrane nanodomains (i.e., lipid rafts), which are areas with 
nonuniform compositions of lipids and proteins relative to the bulk membrane. 
Membrane nanodomains have been shown to play a role in many signal 
transduction events, such as immunoglobulin E (IgE) signaling during the allergic 
immune response, T-cell activation, glial-cell-derived neurotrophic factor signaling, 
and integrin leukocyte function-associated antigen (LFA)-1-mediated cell binding 
(26–30). Cholesterol levels can be modulated in the cell membrane with the use of 
cyclodextrins, which partition cholesterol from cell membranes into their interior 
pores. Cyclodextrins can also partition other membrane components, but 
preferentially extract cholesterol over other lipid components (31). 
In this study, we measured the effect of cholesterol on the microclustering of 
αPS2CβPS integrins expressed in S2 cells using the above-mentioned FRET assay. 
We measured total cellular cholesterol and plasma membrane cholesterol by 
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extraction and Amplex Red assays. In combination, we measured alterations in lipid 
diffusion in live cells using fluorescence recovery after photobleaching (FRAP) under 
native and reduced cholesterol levels. Mechanisms underlying the role of cholesterol 
in αPS2CβPS clustering are postulated. 
 
MATERIALS AND METHODS 
S2 cell culture 
All experiments were performed using transformed Drosophila S2 cells. Cells were 
cultured in Shields and Sang M3 insect medium (Sigma-Aldrich, St. Louis, MO) with 
10% heat-inactivated fetal bovine serum (Irvine Scientific, Santa Ana, CA), 12.5 mM 
streptomycin, 36.5 mM penicillin, and 0.2 mM methotrexate (Fisher Scientific, 
Pittsburgh, PA) in a 22ºC incubator. For the FRET assays, cells were cotransfected 
to express α- and β-integrin subunits and FRET reporters. The complete protein 
sequences for the FRET reporters containing mVenus and mCherry fluorescent 
proteins, and mutant integrin subunits can be found elsewhere (17,32–34). For the 
FRAP assays, cells were transfected to express integrin subunits (i.e., no FRET 
reporters). All of the exogenous proteins contained the heat-shock promoter. 
 
Heat-shock treatment 
Cells were transferred from the cell culture dish to a polypropylene tube and heat-
shocked for 30 min at 36ºC to induce the expression of integrins and/or FRET 
reporters. To achieve maximum protein expression, the cells were then placed in a 
22ºC incubator for 3–4 h, as specified in the sections below. The heat-shock 
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treatment was found to increase total cellular cholesterol by 90%; therefore, heat-
shock treatment was performed before all lipid extractions, FRET, and FRAP 
analyses were conducted. 
 
Cholesterol depletion and restoration 
For cholesterol depletion, cells that had been heat-shocked and incubated for 3 h 
were centrifuged at ~600 x g and the resulting pellet was resuspended at a 
concentration of 2 x 106 cells/mL in serum-free M3 medium containing 2 mM methyl-
β-cyclodextrin (mβCD) (Sigma-Aldrich, St. Louis, MO) and incubated at 22°C for 30 
min. Culturing cells in the absence of serum was tested as a second method for 
reducing cellular cholesterol concentration. Although total cholesterol levels 
decreased by ~40% (day 1), ~60% (day 2), and ~75% (day 3) in the absence of 
serum, there was a concomitant 54–65% increase in cell death relative to control 
cells grown in serum containing medium. Because of the increased cell death, this 
method was not further pursued as a means of modulating cellular cholesterol 
levels. 
For cholesterol restoration, cholesterol-depleted cells were washed with 
serum-free M3 medium and then resuspended in serum-free M3 medium containing 
100 mM cholesterol-loaded cyclodextrin (chol-mβCD) complex (CTD Inc., High 
Springs, FL) for 1 h at 22ºC. Before FRET, FRAP, or lipid extraction were performed, 
the cholesterol-depleted and cholesterol restored cells were washed in serum-free 
medium to remove the cyclodextrin. 
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Extraction of total cellular lipids 
After heat shock and 3 h incubation, the total cellular lipids were extracted using the 
Bligh-Dyer method (35). Briefly, 3.0 mL chloroform/methanol (2:1 v/v) was added to 
1.0 mL medium containing 106 cells followed by vigorous vortexing for 15 min. Then, 
1.0 mL of 1.0 M NaCl was added to the solution and the sample was vortexed for 1 
min. The solution was allowed to sit for 10 min, and the chloroform phase was 
collected and filtered using Whatman filter paper No. 1. The chloroform was 
evaporated under nitrogen, and the cellular lipids were resuspended in phosphate 
buffer containing 0.1 M potassium phosphate, pH 7.4, 50 mM NaCl, 5 mM cholic 
acid, and 0.1% Triton X-100. 
 
Extraction of plasma membrane lipids 
After heat shock and 3 h incubation, plasma membrane lipid extraction was 
performed as previously described (36), with the following minor changes: Cells (3 x 
106) in serum-free M3 media were plated on polylysine-coated glass petri dishes and 
allowed to spread for 2 h at 22˚C. All rinse steps were performed with BES Tyrodes 
buffer. After membrane disruption occurred, the membrane lipid was extracted with 5 
mL chloroform/methanol (2:1 v/v) with continuous rocking for 1 h. The solution was 
collected and added to a glass test tube. The subsequent procedure was similar to 
that described above for the extraction of total cellular lipids. 
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Quantitative measurements of cholesterol 
Cholesterol levels were quantified using an Amplex Red cholesterol assay (Life 
Technologies, Carsbad, CA) without cholesterol esterase (37). This was done to 
ensure that cholesterol esters would not contribute to the measurement. 
Fluorescence was measured with a Synergy HT fluorescence microplate reader 
(BioTek Instruments, Winooski, VT) using an excitation filter of 530/25 nm and 
emission filter of 590/35 nm. Each microplate contained a series of five cholesterol 
standards in triplicate (i.e., 15 standards/ plate) and a blank that were used to 
construct a calibration curve. All values were background-subtracted. Analysis of 
calibration data from 10 replicate microplates indicated that heteroscedasticity was 
present and weighted linear fitting was required (38). Weighted 1/[cholesterol]2 linear 
curve fitting produced the lowest summed relative errors and was used to construct 
the best fit line for each calibration set (see Table S1 in the Supporting Material). 
The unknown cholesterol concentrations were calculated using values from triplicate 
measurements of the same sample, and the calibration function was measured 
using standards on the same microplate. The uncertainty in measuring the 
cholesterol concentration from the calibration functions was determined as described 
in quantitative-analysis textbooks (39). The cholesterol limit of detection (three times 
the standard deviation (SD) in the signal from the blank divided by the slope of the 
weighted calibration curve) was 0.7 mM. All unknowns were at the limit of detection 
or higher. Each data point represents weighted averages from three replicate 
measurements. 
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FRET assay 
After heat shock and 3 h of incubation, the cells were subjected to cholesterol 
depletion/restoration as described above. The cell densities were adjusted to 5 x 105 
cells/mL in serum-free medium before the cells were placed on a ligand-coated 
substrate, prepared as described previously (18). The cells were allowed to spread 
onto the ligand-coated substrate for 1 h, followed by FRET data collection within the 
next hour as described previously (17,18). The FRET data were analyzed using an 
in-house-developed Java plug-in for the software ImageJ. After subtracting the 
background value from each pixel, the plug-in calculates a FRET (Eapp) value on a 
pixel-by-pixel basis using the following equation (40): 
                     
where IDA, IAA, and IDD are intensities obtained from the images with the FRET, 
acceptor, and donor filters, respectively. The terms a, b, c, and d account for the 
bleedthrough in the filter sets, as previously described (17,18). The subtracted 
background value was calculated for each image by averaging several pixels that 
did not contain cells. The background relative SD across an image was 7% for the 
acceptor filter, 6% for the donor filter, and 5% for the FRET filter. The G term in Eq. 
1 is instrument-specific and correlates the decrease in donor fluorescence with the 
increase in acceptor fluorescence due to energy transfer (41). The G-value for the 
instrument setup used in these studies is 1.4. 
The energy transfer measured for each cell is an average of all pixel values 
between the cell edge and the perinuclear region, where intracellular FRET reporters 
contribute to the signal. Analysis of the pixel values from a representative cell 
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provides an average value of 508 and an SD of 22 among 770 pixels. The average 
diameter of the analyzed spread cells was 28 ± 5 microns (αβ Reporters), 33 ± 7 
microns (αanaβ Reporters), 26 ± 6 microns (αβV409D Reporters). These measured 
diameters are indicative of the cells used for the FRET analysis, but not the entire 
cell population. A minimum cell diameter of 20 µm is set for the lower threshold of 
analysis, which is required to distinguish between the perinuclear region and the cell 
edge. The similarity in cell diameters indicates that similar areas are analyzed for 
each cell. 
Every reported FRET value represents an average of the values obtained 
from 100 individual cells obtained over the course of three replicate experiments. All 
FRET data were statistically analyzed using the software JMP 7 (SAS Institute, 
Cary, NC) with statistical consulting from the Department of Statistics, Iowa State 
University. The raw FRET data, being not normally distributed, were log-transformed 
and the means were calculated (42,43). The means of the log-transformed data 
were compared between FRET data sets of treated and untreated cells. After 
unequal variance among the data sets was confirmed, the statistical significance 
between the data sets was assessed by means of Welch t-tests. The significance of 
the statistical test is indicated by p-values. A statistically significant p-value is one 
that is <5%, indicating that the means from the two data sets are not the same. A p-
value > 5% indicates that there is not enough statistical evidence to show 
dissimilarity between the two data sets. The data are reported in the original data 
scale by converting the means of the transformed data as discussed in standard 
statistics textbooks (44). 
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FRAP assay 
After heat shock and 3 h incubation, the cells were subjected to cholesterol 
depletion/restoration as mentioned above. The cell densities were adjusted to 5×105 
cells/mL in serum-free medium. A carbocyanine DiD dye (Life Technologies, 
Carsbad, CA) was added at a final concentration of 11.9 µM. The cells were 
immediately plated onto the ligand-coated substrate and allowed to spread in the 
dark for 1 h. The medium was then replaced with 20 mM BES Tyrodes buffer before 
FRAP analysis was performed. 
The microscope used for these studies contains two excitation light paths: 
one for a 635 nm diode laser (Newport Corp., Irvine, CA) and one for a mercury (Hg) 
lamp. The Hg lamp was used to image the cells before and after the membrane-
incorporated DiD dye was bleached with a laser focused to a 3 µm2 spot. A laser 
shutter and a CCD (Princeton Instruments, Trenton, NJ) shutter were synchronized 
with an external trigger. The trigger timing was 0.40 s between image captures, 0.35 
s for image capture, and 0.35 s for the photobleaching laser pulse. The recovery 
curves from 10 replicate measurements were normalized so that the 
prephotobleached fluorescence intensity would be one. The normalized curves were 
then averaged and divided by a similarly averaged curve generated from a 
nonphotobleached area of each analyzed cell. This latter step accounts for 
photobleaching from the Hg lamp during the recovery period. The resultant curve 
was fit to a double exponential using Igor Pro 6.1 (WaveMetrics, Portland, OR), 
which provided a better fit than a single exponential curve as determined by the χ2  
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values. The diffusion coefficients and percentage of the population with the indicated 
diffusion coefficient were determined from the double exponential fit parameters. 
The listed uncertainty for these parameters was generated from the SD of the 
corresponding coefficients in the double exponential fit. The immobile fraction was 
measured using a previously reported equation for each photobleached corrected 
recovery curve (i.e., before averaging the 10 replicate measurements) and an 
average value was calculated (45). One-way analysis of variance (ANOVA) revealed 
that, for a given cell line, the differences in the measured immobile fraction were not 
statistically significant. 
 
RESULTS AND DISCUSSION 
A schematic of the assay used to measure changes in integrin microclustering due 
to altered cholesterol levels is shown in Figure 2.1. When the separation distance 
between integrins decreases, the separation distance between the donor and 
acceptor FRET peptides decreases, as previously reported (17). This results in more 
energy transfer between the donor and acceptor fluorescent proteins. Similarly, less 
energy transfer is measured when the integrin separation increases, since the 
separation distance between the FRET reporters also increases. The total cellular 
and plasma membrane cholesterol concentrations, lipid diffusion coefficients, and 
integrin microclustering levels were measured in three cell populations: 1), untreated 
cells containing native levels of cholesterol; 2), cells with depleted levels of 
cholesterol; and 3), cells that were first depleted of cholesterol and then restored to 
native levels. A comparison of the measured parameters in the three populations 
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provides evidence for the role of cholesterol in altering the organization of integrins 
in the cell membrane. 
For these studies, we chose to use cell lines derived from Drosophila S2 cells 
transformed to express αPS2CβPS integrins because of the wealth of data available 
on the microclustering of this integrin (17, 18). This enables a direct comparison with 
previous data obtained for the microclustering of this integrin upon alteration of 
cholesterol levels. There is substantial structural homology between vertebrate and 
invertebrate integrins, and many similarities between the integrin-signaling pathways 
(46). In many cases, the information gained regarding integrin microclustering in S2 
cells can be used to advance our understanding of vertebrate integrins. 
Unlike mammalian cells, Drosophila cells are sterol auxotrophs and derive 
sterols from their environment (47, 48). In the case of cultured Drosophila cells, the 
source of the sterols is the fetal calf serum added to the growth medium. As 
confirmed by reverse phase high-performance liquid chromatography, the main 
sterol incorporated in the cell membrane of the cultured cells is cholesterol (Figure 
S1). Fig. 2 A  (black data bars) shows the weighted average total cellular cholesterol 
concentration per cell before cholesterol depletion. The cells utilized in these studies 
expressed wild-type (WT) or mutant integrins and FRET reporter peptides. Two well-
characterized integrin mutants were used in this study. The mutant αanaβ integrin 
contains a two-point mutation in the α-subunit near a site where cytoplasmic proteins 
are known to bind, and is considered to mimic the signal transduction from inside to 
outside the cell (49). The mutant αβV409D integrin contains a single point mutation 
located in the extracellular ligand-binding domain of the β-subunit, and is considered 
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to mimic signal transduction from outside to inside the cell (49). An increased affinity 
for ligand (compared to WT integrins) has been measured for both mutants (17). 
One-way ANOVA confirmed that there were statistically insignificant 
variations in cholesterol levels in untreated cells expressing WT and mutant integrins 
(Fig. 2 A, black data bars). The cholesterol concentration in all three cell lines is 
consistent with previous studies in which 10-14 to 10-16 moles cholesterol/cell were 
measured (50, 51). For all three cell lines after cholesterol reduction with mβCD, 
there was an ~50% reduction in total cellular cholesterol concentration (Fig. 2 A, 
white data bars) relative to untreated cells. 
Plasma membrane cholesterol was measured in untreated and cholesterol-
depleted cells (Fig. 2 B). The plasma membrane lipid extraction protocol isolates 
only a portion of the total cholesterol in the plasma membrane; however, it enables a 
comparison between cells expressing different integrins and cells that have 
undergone different treatments. Similar to the total cellular cholesterol concentration, 
the amount of cholesterol in the plasma membrane does not statistically vary for 
cells expressing WT or mutant integrins. However, after cholesterol depletion with 
mβCD, there is a statistically significant difference in plasma membrane cholesterol 
concentration. There is a 27% decrease in cells expressing WT integrins, a 45% 
decrease in cells expressing αanaβ integrins, and a 57% decrease in cells 
expressing αβV409D integrins. Since there is no statistically significant difference in 
cholesterol concentration in untreated cells or total cellular cholesterol 
concentrations after cholesterol depletion, and since the cells are not exposed to 
serum between cholesterol depletion and lipid extraction, there must be a decrease 
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in intracellular cholesterol concentration upon cholesterol depletion with mβCD. 
Because only cholesterol in the plasma membrane is in direct contact with the 
mβCD solution, it is assumed that only plasma membrane cholesterol is available for 
partitioning into the mβCD. This strongly supports the notion that intracellular 
cholesterol partitions into the plasma membrane as cholesterol is extracted by the 
mβCD to different extents in the three cell lines. 
Plasma membrane phospholipid content was measured as previously 
described in native and cholesterol-depleted cells (36). Although there was a small 
decrease in phospholipid content after cholesterol depletion compared to untreated 
cells, this difference was not determined to be significant by one-way ANOVA. . The 
change in phospholipid concentration (ΔPhospholipid = Puntreated – Pcholesterol reduction) 
was 4.5 x 10-14 moles/cell (p=0.3) αβ; 2.4 x 10-14 moles/cell (p=0.8) αanaβ; 1.9 x 10-
13 moles/cell (p=0.7) αβV409D. 
 
Cholesterol extraction and lipid diffusion coefficients 
Cholesterol has been shown to affect lipid diffusion in the cell membrane (52–
54). To evaluate the role of cholesterol in lipid diffusion in WT and mutant integrin 
expressing S2 cells, we performed FRAP measurements to measure the diffusion 
coefficient of a fluorescent lipid analog: DiD. FRAP involves photobleaching of DiD in 
a defined area in the cell membrane, and then recording the time it takes to 
repopulate the photobleached species by the diffusion of the unbleached dye 
molecules. To avoid any spectral interference due to the fluorescence from the 
FRET reporters, we used cells expressing WT or mutant integrins with no FRET 
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reporter for the FRAP studies. The average recovery curves from 10 replicate 
measurements in cells with native cholesterol levels, depleted cholesterol levels, and 
restored cholesterol levels (αβV409D cell line only) are provided in Fig. S2. The 
parameters calculated from the double exponential fit of the recovery curves are 
shown in Table 1. 
A slow and a fast diffusion coefficient are obtained from the double 
exponential fit parameters. The diffusion coefficients in Table 1  are consistent with 
the values obtained for other cell types, which range from 10-9 – 10-10 cm2/s (52–55 ). 
The slowly diffusing component represents ~50% of the measured diffusing species, 
and the faster component represents the other 50% for all recovery curves analyzed. 
Analysis of the χ2 values indicates that additional exponential terms are not 
warranted in the fit; however, there may be additional species in the membrane that 
are not detectable by FRAP. The origin of the two diffusion coefficients can be 
understood from FRAP measurements using a similar fluorescent lipid mimetic in a 
single-component, solid-supported lipid bilayer (56). The recovery curve is fit to a 
double exponential fit to generate two diffusion coefficients that differ by 
approximately an order of magnitude. Membrane nanodomains would not exist in 
single-component bilayers, and the upper leaflet is exposed only to buffer. In this 
case, the two diffusion coefficients correspond to the leaflet exposed to the solid 
support, which hinders lipid diffusion, and the opposing leaflet. Although the two 
diffusion coefficients measured in the spread S2 cells are orders of magnitude 
slower than those measured for the lipid bilayer, they are most likely the result of 
one leaflet being in contact with the solid support (i.e., 50% of the measured 
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diffusing species) and the opposing leaflet being exposed to the cytoplasm (i.e., the 
other 50% of the measured diffusing species). 
Although there is generally an increase in the slow and fast lipid diffusion 
coefficient in all cell lines after cholesterol depletion (Table 1 , Fig. S2 ), the 
magnitude of the change falls within the uncertainty of the measurement for all cell 
lines, except for the cells expressing the αanaβ  integrins. For this cell line, the fast 
component increases by 50% and the slow component increases by ~22% after 
cholesterol depletion, suggesting that cholesterol reduction increases lipid diffusion 
in the inner leaflet more than in the leaflet exposed to the substrate in this cell line. 
Overall, no correlation can be found between the amount of cholesterol extracted 
from the plasma membrane and the change in the lipid diffusion coefficients in this 
data set. 
An immobile fraction can be measured from the fluorescence recovery 
curves. This parameter corresponds to species that do not diffuse out of the probe 
area, and produce < 100% recovery of the fluorescence after photobleaching. No 
statistically significant differences are found among the immobile fractions measured 
for any of the cell lines with native or depleted cholesterol concentrations (Table 2). 
 
Cholesterol affects integrin microclustering 
Cells were spread on a glass substrate coated with a ligand for the 
αPS2CβPS integrins at a ligand surface density of 3–5%. To ensure that integrin-
ligand interactions were the only mechanism for cell spreading, nonspecific 
interactions with the glass substrate were inhibited by coating the remaining 
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exposed glass with bovine serum albumin. Previous studies found that the 
properties of integrin microclustering are dependent on the ligand’s surface density 
(17,18). Under these conditions, we attempted to elucidate the role of cholesterol in 
integrin microclustering with minimal binding to extracellular ligand. 
Table 3 shows the average FRET values for the three cell lines before and 
after cholesterol depletion. At 3–5% ligand surface density, the mean FRET value for 
cells expressing WT or mutant integrins and FRET reporters indicates statistically 
similar levels of energy transfer for all three cell lines (untreated cells). These results 
indicate similar amounts of integrin microclustering within the assay detection limit in 
all cell lines before cholesterol depletion, and are consistent with previous studies 
(18). 
After the membrane cholesterol concentration is reduced, integrin 
microclustering is altered in two of the three cell lines studied (Table 3, Cholesterol-
depleted cells). There is a statistically significant 50% decrease in energy transfer for 
cells expressing WT integrins after cholesterol reduction, indicating that there is less 
microclustering of αPS2CβPS integrins. For cells expressing αanaβ integrins, there 
is no statistically significant change in energy transfer after cholesterol depletion. 
There is a > 3-fold increase in energy transfer for the cells expressing αβV409D 
mutant integrins after cholesterol depletion. The increase in energy transfer indicates 
that the αβV409D integrins reduce their separation distance by forming higher-order 
oligomers or new oligomers when there is less cholesterol in the membrane. No 
correlation can be made between the change in the measured energy transfer and 
changes in lipid diffusion after cholesterol depletion, since the only cell line that 
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showed a statistically significant increase in lipid diffusion coefficients (αanaβ) did 
not show a statistically significant change in energy transfer. 
The energy transfer measured using the FRET assay depicted in Fig. 1 is a 
result of both integrin-specific interactions with the FRET reporters and potentially 
non integrin specific interactions from many possible sources. Assuming that the 
nonintegrin-specific contributions to energy transfer are similar for the three cells 
lines derived from the S2 parent cell line, the differences in energy transfer listed in 
Table 3  are primarily from integrin-specific interactions with the FRET reporters. 
This is supported by previous studies in which no energy transfer was measured 
within the instrument’s detection limit in cells expressing FRET reporters and no 
integrins, suggesting that the energy transfer measured in cells expressing both 
FRET reporters and integrins is primarily integrin-dependent (17). 
The changes in energy transfer measured after cholesterol depletion report 
on the amount of integrin microclustering that is cholesterol-dependent. There may 
be cholesterol independent integrin microclusters present, which would not result in 
a change in energy transfer after cholesterol depletion. Although the amount of 
integrin microclustering in the cell membrane is similar for all three cell lines before 
cholesterol depletion, the dependence of these microclusters on cholesterol is not 
the same, as determined by different changes in energy transfer after cholesterol 
depletion. This may be due to differences in the integrins’ ligand affinity: αβV409D 
has the highest ligand affinity, followed by αanaβ and then WT. Leitinger and Hogg 
(57) previously showed that lipid nanodomains are involved in the signaling events 
of many classes of integrins. They reported that a mutant LFA-1 integrin missing the 
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I domain has characteristics that mimic integrins with high ligand affinity, and 
preferentially localizes into lipid nanodomains in T lymphocytes, whereas WT LFA-1 
with a low affinity for ligand does not preferentially localize into lipid nanodomains 
under the conditions used in the study. After WT LFA-1 was exposed to Mn2+ or 
phorbol esters, which have been shown to increase ligand affinity for a number of 
integrin classes, the WT LFA-1 increased partitioning into lipid nanodomains. The 
protein and lipid composition of Drosophila membranes supports nanodomain 
formation, and lipid nanodomains enriched in sphingolipids, 
glycosylphosphatidylinositol- linked proteins, and sterols have been measured in 
Drosophila  (58). If αβV409D integrins with a higher ligand affinity than WT 
αPS2CβPS integrins (49) exhibit greater partitioning into lipid nanodomains, this 
might explain the difference in cholesterol-dependent integrin microclustering 
measured in the three cells lines included in this study, as discussed below. 
After cholesterol depletion, αβV409D shows the highest amount of integrin 
microclusters, followed by αanaβ and then WT. Of course, it may seem 
counterintuitive that the integrin with the highest ligand affinity (αβV409D) and 
possibly the greatest partitioning into lipid nanodomains would show the largest 
increase in integrin microclustering upon plasma membrane cholesterol reduction. A 
recent study in T cells showed that the amount of cholesterol extracted from the cell 
membrane affected the resulting change in membrane organization and cell 
signaling originating at the membrane (59). When cholesterol was depleted by < 
50% of its original value (the highest depletion included in the study), lipid 
nanodomains were found to aggregate. Given the amount of cholesterol depleted 
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from the membrane in our studies (Fig. 2 B), it is reasonable to assume that the lipid 
nanodomains are aggregating. This would explain the increase in αβV409D 
microclustering upon cholesterol depletion if it preferentially partitions into 
nanodomains. 
There are several possible explanations for the different amounts of integrin 
microclustering in cells expressing WT and αanaβ integrins. First, less cholesterol is 
extracted from the plasma membrane in these cell populations compared to the 
αβV409D cell line (Fig. 2 B). There may be different levels of lipid nanodomain 
aggregation when less cholesterol is extracted. Additionally, these integrins may 
partition into lipid nanodomains to different extents, or partition into a different 
population of lipid nanodomains. It has been shown that the extent to which certain 
proteins partition into lipid nanodomains depends on the amount of cholesterol in the 
membrane (59). The population of WT integrins in lipid nanodomains may decrease 
(by partitioning out or by nanodomain disruption) upon 27% cholesterol extraction 
from the plasma membrane. This would explain its decreased microclustering upon 
cholesterol depletion. Studies with additional integrin mutants could further test the 
hypothesized relationship between ligand affinity, partitioning into lipid nanodomains, 
and cholesterol-dependent microclustering. 
Previous studies have shown that treatment with mβCD can extract 
membrane phospholipids along with cholesterol (31), and that restoration of 
membrane properties, such as diffusion coefficients, can be achieved by restoring 
the cholesterol levels to their original values (24). We confirmed the role of 
cholesterol in altering membrane properties by adding cholesterol back to the 
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membrane of previously cholesterol-depleted cells and reevaluating those 
properties. The cholesterol-depleted, αβV409D-expressing cells were incubated with 
chol-mβCD, and the total cellular and plasma membrane cholesterol concentrations 
were measured. Fig. 2, A and B (gray data bars) show that the total cholesterol and 
plasma membrane cholesterol levels in cells expressing the αβV409D mutant 
integrins and FRET reporters can be restored to a level statistically similar to that of 
untreated cells at the 95% confidence level. After cholesterol restoration, the slow 
and fast lipid diffusion coefficients show a statistically significant decrease relative to 
the values obtained for the cholesterol-depleted cell line (Table 1). Similarly, the 
FRET results (Table 3) indicate that αβV409D integrin microclustering levels return 
to a value statistically similar to that of the original value obtained for the untreated 
cells. Although this provides evidence that cholesterol plays a role in the altered 
membrane properties measured in this study, it cannot be concluded that other 
membrane components are not playing a role. It is possible that mβCD may perturb 
another membrane component(s) that also affects integrin microclustering, and this 
change is convoluted with that obtained upon cholesterol depletion. If this is the 
case, the FRET assay utilized in this study will be an ideal analysis technique to 
identify other lipid or membrane components that affect integrin microclustering. 
Current research is being performed to identify additional membrane species with a 
role in altering integrin microclustering. 
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CONCLUSIONS 
Integrins are ubiquitous membrane receptors that are important in nearly all 
cell-signaling cascades, including those that control basic cellular functions (60–62). 
Therefore, it is important to understand the molecular mechanism of integrin 
function. This includes not only the much-studied changes in ligand affinity and 
macroscale clustering, but also the less-studied changes in receptor microclustering. 
The data reported herein highlight a simple method that can be used to elucidate the 
role of cholesterol in integrin microclustering. Upon cholesterol depletion, the 
maximum increase in integrin microclustering was measured for cells expressing 
αβV409D integrins, which have the highest affinity for ligand of the three integrins 
included in this study. Partitioning into cholesterol-rich nanodomains may explain the 
difference in cholesterol-dependent integrin microclustering for WT and mutant 
integrins. Restoration of membrane cholesterol to native levels restored the levels of 
αβV409D integrin microclustering to values obtained for untreated cells. A similar 
methodology can be used to elucidate the role of cholesterol in the microclustering 
of integrins in other cell types, as well as the role of other membrane components in 
integrin microclustering and for other members of the integrin family. 
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Table 1. Slow and fast lipid diffusion coefficients measured from the fluorescence 
recovery curves for the untreated cells, cholesterol depleted cells and (αβV409D cell 
line only) cholesterol restored cells. 
 
 Untreated Cells1 Cholesterol depleted cells
1 Cholesterol restored cells1 
Cell Line 
Diffusion 
Coefficient 
(cm2/s) 
 
 
Percent of 
population 
Diffusion 
Coefficient 
(cm2/s) 
 
 
Percent of 
population 
Diffusion 
Coefficient 
(cm2/s) 
 
 
Percent of 
population 
αβ Reporters 
4.4 x 10-10 ± 
0.7 x 10-10 50 ± 10 
3.4 x 10-10 ± 
0.5 x 10-10 46 ± 6 - - 
2.5 x 10-9 ± 
0.3 x 10-9 50 ± 10 
2.8 x 10-9 ± 
0.3 x 10-9 57 ± 7 - - 
αanaβ 
Reporters 
5.0 x 10-10 ± 
0.6 x 10-10 50 ± 20 
6.1 x 10-10 ± 
0.4 x 10-10 55 ± 4 - - 
2.0 x 10-9 ± 
0.2 x 10-9 50 ± 10 
4.0 x 10-9 ± 
0.6 x 10-9 45 ± 1 - - 
αβV409D 
Reporters 
4.1 x 10-10 ± 
0.5 x 10-10 50 ± 9 
4.7 x 10-10 ± 
0.9 x 10-10 40 ± 10 
3.2 x 10-10 ± 
0.6 x 10-10 44 ± 8 
2.5 x 10-9 ± 
0.3 x 10-9 50 ± 10 
3.0 x 10-9 ± 
0.4 x 10-9 60 ± 10 
2.2 x 10-9 ± 
0.2 x 10-9 56 ± 9 
1 Parameters calculated from double exponential fit to the average curve generated from ten replicate 
measurements ± the standard deviation calculated from the uncertainty of the corresponding 
coefficients obtained in the double exponential fit. 
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Table 2. Average percent immobile fraction measured from ten replicate 
fluorescence recovery curves for the untreated cells, cholesterol depleted cells and 
cholesterol restored cells (αβV409D cell line only). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1Statistical significance was tested with one way ANOVA, and the results are indicated  
by the p-values.  
Cell Lines Untreated cells1 Cholesterol depleted cells1 
Cholesterol 
restored  cells1 
αβ Reporters 13.1 12.9 (p = 0.95) - 
αanaβ Reporters 11.9 16.1 (p=0.18) - 
αβV409D 
Reporters 12.2 
9.2 
(p = 0.3) 
13.9 
(p = 0.5) 
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Table 3. Integrin microclustering levels measured by FRET for the untreated cells, 
cholesterol depleted cells and (αβV409D cell line only) cholesterol restored cells 
 
Cell Lines Untreated cells1 Cholesterol depleted cells1 
Cholesterol 
restored  cells1 
αβ Reporters 0.010 0.005 (p=0.02) - 
αanaβ 
Reporters 0.011 
0.014 
(p=0.36) - 
αβV409D 
Reporters 0.008 
0.026 
(p=0.0001) 
0.006 
(p=0.45) 
1 Statistical significance was tested with a Welch t-test, and the results are indicated  
by the p-values.   
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Figure 1. Schematic of the FRET assay used to measure integrin microclustering 
with donor and acceptor FRET reporters. Energy transfer is measured (top) prior to 
altering the plasma membrane cholesterol level; (middle) after reducing the 
concentration of cholesterol; and (bottom) after restoring cholesterol levels to 
approximately the starting concentration before treatment. 
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Figure 2. Graphs showing the weighted average of total cellular cholesterol per cell 
(A) and plasma membrane cholesterol (B) in three cell populations (black) untreated 
cells before cholesterol reduction; (white) after reduction with mβCD to extract 
cholesterol; and (gray) after adding chol-mβCD to the growth medium to restore 
cholesterol levels (αβV409D cell line only). Error bars represent weighted standard 
deviations from three replicate experiments. P-values indicate comparisons to 
untreated cells obtained using one way ANOVA. Details of the cell lines are found in 
the text.  
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SUPPORTING INFORMATION FOR APPENDIX A 
Table S1. Summation of the percent relative error obtained from for the Amplex Red 
calibration functions using the indicated weighting model. Weighting 1/[cholesterol]2 
was used to construct all Amplex Red calibration plots. 
 
 
weighting model  ∑ (% relative error) 
 
no weighting 3891 
 
1/[cholesterol]1/2 1598 
 
1//[cholesterol] 850 
 
1//[cholesterol]2 672 
 
1/(fluorescence intensity)1/2 1738 
 
1/(fluorescence intensity) 929 
 
1/(fluorescence intensity)2 731 
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Figure S1. Lipid extracts obtained with the Bligh-Dyer method, were analyzed using 
High Performance Liquid Chromatography (HPLC) with a UV-Vis detector (Agilent, 
USA). A reverse phase C-18 column (ZORBAX Eclipse XDB-C18, 4.6x150mm, 5 
µm) was used with a flow rate of 1.0 ml/min. The absorbance was monitored at 205 
nm wavelength. The mobile phase solvents consisted of 3% water and the 
remaining 97% consisted of acetonitrile/methanol (50/50, v/v). 5 µL of the lipid 
extract was injected into the column. Chromatogram of lipid extract from transformed 
Drosophila S2 cells expressing αPS2CβPS integrins. Traces represent lipid extract 
from cells (black) and lipid extract spiked with a cholesterol standard (red). 
Cholesterol was found to be the main sterol in the cells used in these studies.  
 
!
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Figure S2. Normalized fluorescence recovery curves representing the average of 
ten replicate measurements (symbols). The fluorescence is from a carbocyanine 
lipid mimetic, DiD. The curves have been photobleach corrected by dividing the 
fluorescence intensity of the bleached spot by the fluorescence intensity of a non-
photobleached spot approximately 20 pixels away. The data are fit to a double 
exponential curve (dotted lines, cholesterol depleted cells; solid lines, control and 
cholesterol restored cells). The fit parameters are discussed in the text. 
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APPENDIX B 
ELUCIDATING THE ROLE OF SELECT CYTOPLASMIC PROTEINS 
IN ALTERING DIFFUSION OF INTEGRIN RECEPTORS 
A paper published in the special issue Young Investigators in Analytical and 
Bioanalytical Science 2012* 
Suzanne Sander, Neha Arora and Emily A. Smith 
ABSTRACT 
 Cytoplasmic proteins that affect integrin diffusion in the cell membrane are 
identified using a combination of fluorescence recovery after photobleaching (FRAP) 
and RNA interference. Integrin receptors are essential for many cellular events, and 
alterations in lateral diffusion are one mechanism for modulating their function. In 
cells expressing native cytoplasmic protein concentrations and spread on a slide 
containing integrin extracellular ligand, 45 ± 2% of the integrin is mobile with a time-
dependent 5.2 ± 0.9 x 10-9 cm2/sec diffusion coefficient at 1 second. The time 
exponent is 0.90 ± 0.07, indicating integrin diffusion moderately slows at longer 
times. The role of a specific cytoplasmic protein in altering integrin diffusion is 
revealed through changes in the FRAP curve after reducing the cytoplasmic 
protein’s expression. Decreased expression of cytoplasmic proteins rhea, focal  
adhesion kinase (FAK) or steamer duck decreases the integrin mobile fraction. 
For rhea and FAK there is a concomitant shift to Brownian (i.e., time-independent) 
 
 
*Reprinted with permission from The Journal of Analytical and Bioanalytical 
Chemistry Copyright © Springer 2012 
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diffusion at reduced concentrations of these proteins. In contrast, when the 
expression of actin 42A, dreadlocks, paxillin, integrin expression. Decreased 
expression of cytoplasmic proteins rhea, focal adhesion kinase (FAK) or steamer 
duck decreases the integrin mobile fraction. For rhea and FAK there is a  
concomitant shift to Brownian (i.e., time-independent) diffusion at reduced 
concentrations of  these proteins. In contrast, when the expression of actin 42A, 
dreadlocks, paxillin, integrin linked kinase (ILK), or vinculin is reduced, integrin 
diffusion generally becomes more constrained with an increase in the integrin mobile 
fraction. This same change in integrin diffusion is measured in the absence of 
integrin extracellular ligand. The results indicate breaking the extracellular ligand-
integrin-cytoskeletal linkage alters integrin diffusion properties, and, in most cases 
there is no correlation between integrin and lipid diffusion properties.  
 
INTRODUCTION 
Alterations in the lateral diffusion of lipids, proteins, and small molecules in 
the cell membrane occur in response to a variety of stimuli, ranging from protein 
binding [1] to mechanical forces emanating from inside or outside the cell [2,3]. The 
unrestricted lateral diffusion coefficient of membrane components can be roughly 
estimated by the Saffman-Delbrück equation [4]. Calculated values are on the order 
of 10-8 cm2/sec for a typical membrane protein, and lipids have similar diffusion 
coefficients that are larger only by a factor of ~2 [5,6]. The lateral diffusion of 
membrane proteins is usually slower than values measured for proteins in model 
lipid bilayers and values calculated using the Saffman-Delbrück equation [7,8]. This 
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is due to three primary factors: (1) membrane proteins interact with extracellular and 
cytoskeletal/cytoplasmic proteins; (2) the cell membrane contains a high 
concentration of proteins, e.g. 50-80% of the membrane surface area; and (3) 
membrane components may be confined to domains of varying size, all of which 
constrain lateral diffusion. In erythrocyte cells lacking key cytoskeletal proteins, the 
lateral diffusion of a membrane protein increased over 50-fold compared with cells 
containing all cytoskeletal proteins, indicating that cytoplasmic proteins play a role in 
altering the lateral diffusion of at least some membrane components [9]. Altered 
lateral diffusion of mutant membrane proteins with cytoplasmic domains that have 
been eliminated or shortened can reveal the role of cytoplasmic domains in altering 
lateral diffusion, but they do not provide information about specific cytoplasmic 
proteins that may be responsible for altered lateral diffusion.  
Several analytical techniques can be used to measure lateral diffusion of 
membrane components. Single particle tracking [10] and fluorescence correlation 
spectroscopy [11] can be used to reveal heterogeneous diffusion of membrane 
components. These techniques require approximately nanomolar concentrations of 
analyte (e.g., fluorophore labeled protein), which is often significantly below relevant 
in vivo concentrations [12]. Fluorescence recovery after photobleaching (FRAP) can 
be used to monitor the time required for fluorescent molecules to laterally diffuse into 
a region of the cell that has previously been photobleached.  The photobleached 
region can be generated by a short, intense laser pulse. FRAP is an ensemble 
measurement that averages the movement of numerous proteins, which may 
represent populations with different diffusion characteristics. Possible rare 
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populations may be masked in the ensemble measurement. Fluorescent fusion 
proteins enable in vivo and ex vivo FRAP measurements of a membrane protein at 
endogenous expression levels [13]. Several models have been developed to extract 
diffusion parameters of membrane components from fluorescence recovery curves 
[14-16]. Combined with techniques to alter the expression of other proteins, FRAP 
has the capability for measuring the molecular mechanism of receptor diffusion in 
the cell membrane.  
Integrins are a family of heterodimeric receptors that contain an α and a β 
subunit with large extracellular domains and comparatively short cytoplasmic 
domains [2]. Several cytoplasmic proteins interact directly or indirectly with integrins; 
however, the effects of such interactions in altering their lateral movement in the cell 
membrane are not well understood. A method utilizing FRAP has been described to 
elucidate the dynamics of focal adhesions, which are integrin containing 
macromolecular assemblies that link cells to the extracellular matrix [17]. In this 
previously published method, the lateral mobility was measured for integrin mutants 
that disrupt known binding sites to other focal adhesion proteins, and was limited to 
study proteins that directly bind at known locations on the integrin. The cloning step 
required to generate integrin mutants also makes the methodology low-throughput. 
FRAP has also been used to measure changes in integrin diffusion when bound to 
multimeric ligands compared with monovalent ligands [18]. It was shown that integrin 
lateral diffusion decreases when bound to a tetrameric ligand compared to a 
monovalent ligand.  
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In this current study, RNA interference (RNAi) was used to decrease the 
expression of select cytoplasmic proteins and the resulting changes in lipid and 
integrin diffusion were subsequently measured by FRAP in Drosophila melanogaster 
S2 cells (Fig. 1) [19-22]. Whole-genome RNAi studies have primarily measured an 
easily observed cellular phenotype.  When a more complex property such as 
membrane diffusion is measured, whole-genome studies become less economically 
and experimentally feasible. However, measuring a chosen subset of target proteins 
can be insightful. The cytoplasmic proteins included in this study for RNAi targeting 
include focal adhesion kinase (FAK), rhea, integrin linked kinase (ILK), paxillin, 
vinculin, dreadlocks, steamer duck, actin 42A, and akt1. These proteins have a role 
in integrin signaling, associate with integrins or the cytoskeleton. Focal adhesions 
incorporate vinculin, paxillin, rhea, and FAK. Akt1 is a kinase that is not located 
within focal adhesions, but it is known to interact with them via the PI-3 kinase [23]. 
Steamer duck and ILK are part of a protein complex that is assembled prior to 
integrin-dependent cell adhesion [24]. Dreadlocks is involved in cytoskeletal 
reorganization [25], and actin 42A is one of 6 actins expressed in S2 cells.  All of the 
proteins selected in this study are highly conserved across diverse organisms, and 
information obtained from these experiments will expand the fundamental 
understanding of integrins function [26,27]. Rhea, dreadlocks, and steamer duck are 
homologs for the vertebrate proteins talin, Nck-2, and pinch, respectively. The 
fluorescence recovery curves were modeled to obtain diffusion coefficients, mobile 
fractions and modes of diffusion, which were compared before and after RNAi 
treatment.  In addition to FRAP measurements, real time polymerase chain reaction 
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(RT PCR) was used to measure a reduction in mRNA concentration after RNAi 
treatment.   
 
METHODS 
Cell Preparation 
S2 cells were cultured in Shields and Sang M3 medium (M3, Sigma) with 
antibiotics and 10% fetal calf serum (FCS) as previously published [28]. Permanently 
transfected S2 cells expressed wild-type αPS2CβPS integrins (αβ), or αPS2CβPS 
integrins with a Venus yellow fluorescent protein (αβ-Venus) inserted in the serine 
rich loop. The serine rich loop is an extracellular domain that has been previously 
used to insert epitope tags into this integrin without disrupting the integrin function 
[29]. The αβ cell line was used to measure lipid diffusion and the αβ-Venus cell line 
was used to measure integrin diffusion. The αPS2CβPS integrin binds to the 
extracellular ligand tiggrin. These studies utilized a recombinant version of this 
protein, [30] whose concentration was determined via gel electrophoresis. Ligand 
coated microscope slides were prepared as previously described using 0.5 µg mL-1 
tiggrin [31].   
Synthesis of double stranded RNA (dsRNA) and RNAi treatments have 
previously been described [32,33]. The cells were incubated with dsRNA for 4 days 
at 22˚C prior to analysis. The expression of all target proteins in S2 cells was 
confirmed using FLIGHT mRNA microarray expression database [34] and 
PeptideAtlas mass spectrometry proteomics database [35].  
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Fluorescence Recovery After Photobleaching 
After incubation with dsRNA, the cells were transferred to a 14 mL centrifuge 
tube and heat shocked in a 36˚C water bath for 30 minutes to induce expression of 
integrins, which were under the control of the heat shock promoter. The cells were 
placed in a 22˚C incubator for 3 hours, and then centrifuged at 600xg for 3 minutes. 
The supernatant was removed and the cells were resuspended in M3 medium 
without FCS at a final concentration of 3 x 105 cells mL-1. For lipid diffusion 
measurements the M3 medium contained carbocyanine dye DiD (Invitrogen, 1,1'-
dioctadecyl-3,3,3',3'- tetramethylindodicarbocyanine perchlorate) at a final 
concentration of 12 µM. For all measurements, 50 µl of cells were plated onto a 
tiggrin coated slide and allowed to spread for 1 h before rinsing the slide with BES 
Tyrodes buffer (200 mM BES, 1.37 M NaCl, 29 mM KCl, 1% w/v glucose, 1% w/v 
bovine serum albumin).  
All fluorescence measurements were performed at room temperature utilizing 
an Eclipse TE2000U microscope (Nikon). A series of fluorescence images were 
collected before photobleaching the fluorophore and after photobleaching (recovery) 
using mercury lamp excitation. Example images are shown in Fig. 1. The exposure 
time for each image was 0.35 seconds, and images were collected every 0.40 
seconds. Photobleaching was accomplished with a laser, as outlined below. Lipid 
diffusion measurements used a x60 magnification, Plan Apo, 0.95 numerical 
aperture objective and a 635 nm diode laser (~300 µW at sample) was used to 
photobleach a 37 µm2 area of the plasma membrane labeled with DiD. Images were 
collected using a 645/20 nm excitation and a 660/20 nm emission filter.  Integrin 
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diffusion measurements used a x100 magnification, Apo TIRF, 1.49 numerical 
aperture, oil immersion objective and the 488 nm line of an argon ion laser (~250 
µW at sample) to photobleach a 41 µm2 area of the cell membrane containing αβ-
Venus. Venus images were collected using a 500/20 nm excitation and a 535/30 nm 
emission filter. The Venus fluorescence intensity was lower than that for DiD; 
therefore, for Venus measurements the gain on the Princeton Instrument PhotonMax 
512 CCD was set to its maximum value. Integrin diffusion coefficients were 
measured on ligand/BSA-coated or BSA-coated (10 mg mL-1) glass slides. No cell 
movement is measured in the time required to collect a complete FRAP data set. All 
fluorescence measurements included in this study were obtained on spread cells in 
the region between the perinuclear region and the cell edge (Fig. 1) to ensure that 
fluorescence contributions from intracellular YFP is minimal, as previously confirmed 
[31]. The focus was set to the apical surface, and the thickness of the cells ensures 
that the apical and basolateral surfaces are not probed simultaneously.  
 
Data analysis 
Fluorescence images were analyzed using ImageJ version 1.38. Three 
intensities were measured for every image of the FRAP series: (1) the 
photobleached area of the plasma membrane corresponding to the area illuminated 
by the laser spot; (2) an area of the plasma membrane 10 µm away from the 
photobleached spot (No FRAP); and (3) a background area 30 µm away from the 
cell (background).  All fluorescence intensities were background subtracted. FRAP 
curves are an average from seven to ten replicate measurements, and were 
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normalized to the pre-photobleach fluorescence intensity. To account for 
photobleaching from the mercury lamp during the recovery phase, the average 
recovery curve was divided by the average No FRAP fluorescence intensity at each 
time point.  
The fluorescence recovery curves were fit to models based on Eq. 1[36] with 
an in-house developed Igor Pro macro (version 4.0).  
                 
(1)
  
The parameter F0 is the initial fluorescence intensity after photobleaching; Fin is the 
fluorescence intensity at an infinite recovery time; t is the time for 50% of the 
fluorescence to recover; and α is the time exponent providing a measure of how 
much diffusion is constrained. Every FRAP curve was fit to three models. (1) The 
Brownian diffusion model sets α = 1 and allows Fin < 1, corresponding to an 
immobile fraction. (2) The constrained, time-dependent diffusion model assumes no 
immobile fraction by setting Fin = 1. (3) The third model incorporates time-dependent 
diffusion with an immobile fraction. Fits to the FRAP curve were weighted to the 
standard error of the pre-bleach fluorescence intensity. The reduced chi2 was 
calculated as chi2 divided by the experimental degrees of freedom (Table 1). The 
reduced chi2 values were compared to determine the most appropriate model for 
each data set, and a value of 1 indicates a good fit between the model and the 
experimental data. 
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 The mobile fraction was calculated as: (Fin - Fo)/(1 - Fo). The immobile fraction 
is 1 minus the mobile fraction. The diffusion coefficient, D(t), was calculated by 
inserting τ and α obtained from the fit of the fluorescence recovery curve into Eq. 2.  
(2)  
where ω is the radius of the focused Gaussian laser beam and β is 1.075, 1.13, 
1.15, 1.18, 1.22, or 1.26 when the percent photobleach is 30, 45, 50, 55, 60, and 65, 
respectively. Diffusion parameters obtained for the best-fit model are listed in Tables 
2 and 3 while those for the other models are shown in the Electronic supplemental 
material Tables S1 and S2. Error bars on all reported FRAP fit parameters represent 
uncertainties at the 95% confidence level. 
 
RT-PCR 
Isolation of mRNA from ~4x106 cells was achieved using Dynabeads mRNA 
Direct kit (Invitrogen 610.12) and quantified using the absorbance value at 260 nm. 
The reverse transcription of mRNA to cDNA (Applied Biosystems #4387406) was 
carried out at 37°C for 60 minutes and the reaction terminated at 95°C for 5 minutes. 
The cDNA was combined with master mix (Applied Biosystems #4369016) and gene 
expression assay for the corresponding gene (Applied Biosystems: rhea 
Dm01841094_g1, FAK Dm01816810_m1, ILK Dm01843539_g1, actin 42A 
Dm02362162_s1, vinculin Dm01841855_g1, paxillin Dm02772085_s1, steamer 
duck Dm02135515_g1,  dreadlocks Dm01842270_g1, akt1 Dm02149560_g1, 
myospheroid Dm01843062_ g1, gamma tubulin at 23C Dm01841764). RT PCR 
1
2
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used an initial temperature of 95°C for 10 minutes to activate the enzyme, followed 
by 40 cycles (95°C for 15 s then 60°C for 60 s). Calibration curves were constructed 
using genomic DNA that was isolated from S2 cells with a Qiagen Kit (#69504). All 
steps were performed according to the manufacturers' provided protocols. Statistical 
significance of the results was determined using the software Rest 2009 [37].  
 
RESULTS AND DISCUSSION 
Integrin and lipid diffusion parameters at native cytoplasmic protein 
concentrations 
The main goal of this study was to elucidate the role of select cytoplasmic 
proteins in altering the lateral diffusion of αPS2CβPS integrins and lipids in the cell 
membrane of live S2 cells. Integrin diffusion coefficients were measured for cells 
spread on a mixed extracellular ligand/bovine serum albumin (BSA) coated 
microscope slide before RNAi treatment to obtain integrin diffusion parameters at 
native cytoplasmic protein concentrations. The extracellular ligand used in this study 
was a recombinant version of tiggrin, the native ligand for αPS2CβPS integrins. BSA 
fills in areas of the slide not occupied by ligand and prevents non-specific 
interactions between cell membrane components and the glass slide.  
The average integrin FRAP curve from replicate measurements (Fig 2A) was 
fit to models for (1) Brownian diffusion with an immobile fraction, (2) constrained, 
time-dependent diffusion or (3) time-dependent diffusion with an immobile fraction. 
For cells spread on a ligand coated slide, the reduced chi2 value for each model was 
1.3, 4.7, and 1.2, respectively (Table 1, control ligand). This indicates that integrin 
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diffusion in the cell membrane is best-modeled by time-dependent diffusion with a 55 
± 2% immobile fraction.  The integrin diffusion coefficient is 5.2 ± 0.9 x 10-9 cm2/sec 
at 1 s, and slows to 3.6 ± 0.6 x 10-9 cm2/sec at 50 s (Table 2, control ligand). 
Hereafter short analysis times refer to the diffusion coefficient at 1 s and long 
analysis times refer to the diffusion coefficient at 50 s. The time-dependent diffusion 
coefficient may be the result of periodic interactions with intracellular proteins, 
extracellular ligand, other membrane components; integrins undergoing 
conformational changes; or integrins partitioning between domains smaller than the 
probe area of the FRAP experiment and the bulk membrane. Similarly, there are 
many plausible explanations for the measured integrin immobile fraction. For 
example, the immobile integrin may be (1) bound to ligand immobilized on the 
microscope slide, (2) confined to nanoscale domains that do not exchange with the 
bulk membrane on the time scale of the FRAP experiment, (3) bound to a static 
cytoplasmic component or (4) a combination of aforementioned factors.  
To determine if the immobile fraction or the diffusion properties of the mobile 
integrin are ligand-dependent, FRAP curves were measured in cells spread on a 
BSA coated slide in the absence of ligand. The integrin immobile fraction is expected 
to decrease in the absence of ligand if this fraction represents ligand-bound protein. 
Comparing integrin FRAP curves in the presence or absence of ligand, the time-
dependent diffusion with an immobile fraction model best-fits both curves (Table 1).  
The immobile fraction decreases from 55 ± 2% to 30 ± 3% in cells spread in the 
absence of integrin ligand (Table 2). The difference between these two numbers 
indicates that 25% of the immobile fraction is ligand-dependent, and this fraction 
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likely represents integrin that is bound to immobile ligand.  For cells spread on a 
ligand containing slide, the remaining 30% ligand-independent immobile fraction 
may be the result of hindered diffusion due to the presence of the microscope slide 
or any of the remaining explanations listed above. The percentage of the immobile 
fraction that is ligand-dependent or ligand-independent may vary with the ligand 
concentration. The diffusion properties of the mobile integrin fraction are also altered 
in cells spread in the absence of ligand. Interestingly, the increase in the mobile 
fraction is accompanied by a 50% slower diffusion coefficient at long analysis times 
for cells spread in the absence of ligand (Table 2). This indicates that the 
extracellular matrix (ECM)-integrin linkage reduces diffusion constraints in the 
mobile fraction and at the same time reduces the fraction of integrins that are 
mobile.  
In contrast to the integrin diffusion properties, the lipid diffusion properties are 
independent of the presence or absence of extracellular ligand.  A combination of 
reduced chi2 values for the three diffusion models (Table 1) and time exponents 
equal to approximately 1 indicate that the lipid diffusion is Brownian (Table 3). The 
lipid mobile fraction is 35% higher than the integrin mobile fraction, and the lipid 
diffusion coefficient is approximately an order of magnitude faster (Table 3). The lipid 
diffusion coefficient is 30 ± 3 (ligand) or 30 ± 2 (no ligand) x 10-9 cm2/sec (Table 3). 
The lipid diffusion parameters are consistent with several literature reports using 
different cell lines and experimental conditions [38,39]. The fastest diffusion 
coefficient that can be measured with the experimental parameters used in this 
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study is 100 x 10-9 cm2/sec as revealed by modeled FRAP curves associated with 
varying diffusion coefficients (Fig. S1, green Electronic supplementary material).  
 
Reduced mRNA Concentration for RNAi targeted proteins 
RNAi requires the lipid-assisted cellular uptake of approximately 500 base 
pair dsRNA (RNAi probe). Both the efficiency of getting the RNAi probe inside the 
cell and the RNA sequence can affect the achieved reduction in protein expression, 
among other factors [19]. In order to limit false positives and false negatives in the 
fluorescence measurements, RNAi probes for the target proteins were chosen 
based on their use in previous RNAi screens, thermodynamic binding efficiency and 
selectivity for the target protein [40]. Based on a trypan blue assay, there is no 
change in cell viability after any of the RNAi treatments [31,40].  
RT PCR confirmed statistically significant reductions in mRNA concentrations 
after RNAi treatment for all target proteins (Table 1). The largest reduction was 
measured for actin 42A (90 to 92%) and the smallest reduction was for paxillin (25 to 
43%). Reduction of one component of the trimeric protein complex consisting of ILK, 
pinch (the vertebrate homolog to steamer duck), and parvin may cause partial 
degradation of the other components within the complex via a proteasome-mediated 
process, which would not be reflected in the RT PCR data [24]. RNAi selectivity for 
these proteins may be low.  
There were no statistically significant changes in the mRNA concentration for 
the βPS integrin subunit after RNAi treatment for any of the target cytoplasmic 
proteins included in this study (data not shown). Supporting the RT-PCR data, the 
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αβ-Venus fluorescence intensity in the cell membrane was statistically similar in cells 
before and after RNAi treatment for all target proteins (data not shown). Comparable 
αβ-Venus fluorescence intensities among all treatments indicate that the membrane 
integrin concentration is not significantly perturbed upon reducing the expression of 
the target cytoplasmic proteins.  
 
Changes in integrin diffusion at reduced cytoplasmic protein concentrations  
Integrin FRAP curves from replicate measurements were collected after RNAi 
treatment against nine cytoplasmic proteins (Fig. 2). As shown in Table 1, for all 
curves except rhea, focal adhesion kinase and akt1, the model for time-dependent 
diffusion with an immobile fraction is the best fit. For rhea, focal adhesion kinase and 
akt1, the FRAP curves are fit equally well by the Brownian diffusion and time-
dependent diffusion model, and similar diffusion parameters are obtained from both 
models. For these cytoplasmic proteins there are no or fewer diffusion constraints 
after reducing their expression. 
Table 2 shows the measured diffusion parameters obtained from the FRAP 
curves for cells that were RNAi treated for the indicated cytoplasmic protein. In 
subsequent discussion all values for the RNAi treated cells are compared to the 
control value for cells spread on a ligand coated surface. In general, two changes to 
integrin diffusion occur after reducing the concentration of the targeted cytoplasmic 
proteins.  For a subset of proteins (actin 42A, dreadlocks, paxillin, ILK, vinculin) 
integrin diffusion generally slows at longer times with an increase in the integrin 
mobile fraction.  This indicates that when these proteins are expressed at native 
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concentrations integrin diffusion is less constrained. For a second subset of proteins 
(rhea, FAK) the opposite trend is observed. This indicates that these proteins result 
in more constrained diffusion when they are expressed at endogenous levels. After 
steamer duck RNAi, there is no statistically significant change in the integrin 
diffusion coefficient, but the mobile fraction decreases. RNAi against akt1 increases 
the integrin mobile fraction and results in Brownian diffusion with an overall slower 
diffusion coefficient. 
Cells were spread on a ligand coated microscope slide for all FRAP 
measurements performed after the RNAi treatments.  When the expression of actin 
42A is reduced, the profile of integrin diffusion mimics that measured for cells spread 
on a microscope slide in the absence of ligand (Table 2). At reduced actin 42A 
concentrations or in the absence of ligand there is a ~ 25% increase in the integrin 
mobile fraction and a 50 to 70% decrease in the diffusion coefficient at long analysis 
times. In human osteosarcoma and mouse embryonic fibroblast cells no direct 
physical interaction takes place between integrin and actin proteins, as measured 
with a sub-diffraction fluorescence imaging technique [41]. The integrin cytoplasmic 
tail and actin are separated by approximately 40 nm. Within the intervening region 
several adapter proteins are found (e.g. FAK, paxillin, rhea, vinculin).  Reduced 
expression of paxillin or vinculin mimics the changes in integrin diffusion measured 
when actin 42A expression is reduced. Whereas reducing the expression of rhea 
and FAK has the opposite effect as reducing the expression of actin 42A.  
A key function of rhea is to connect ligand-bound integrin to the actin 
cytoskeleton, but rhea is not required for integrin binding to ligand. Talin, the 
  
 
146 
vertebrate homolog to rhea, has a role in the avidity regulation of integrins [42]. 
Increased integrin clustering in the presence of rhea may explain why reduced rhea 
concentrations result in Brownian diffusion with a faster diffusion coefficient. The αβ-
Venus fluorescence images before RNAi treatment do not show integrin clusters that 
are larger than the diffraction limit of light. The Saffman-Delbrück equation predicts 
that the integrin clusters would only have to contain a few proteins at endogenous 
rhea concentrations (i.e., smaller than the diffraction limit of light) to result in the 
approximately 30% increase in integrin diffusion measured after reducing the 
concentration of rhea. When the expression of ILK is reduced by RNAi there is a 
two-fold increase in integrin clusters that are smaller than the diffraction limit of light 
(manuscript in preparation). It is not known if existing clusters increase in size or if 
more clusters develop. The Saffman-Delbrück equation predicts a 20 to 40% 
decrease in the diffusion coefficient when integrin clusters double in size, but remain 
smaller than the diffraction limit of light. The measured change in integrin diffusion 
after reducing the expression of ILK could be the result of increased integrin 
clustering.  
A recent paper has shown that reducing levels of vertebrate talin in a 
fibroblast cell line affected FAK signaling during cell spreading on fibronectin [43]. 
Total FAK levels did not change, but levels of phosphorylated Tyr397 were 
attenuated in talin depleted cells.  Altered FAK signaling may be the mechanism for 
altered integrin diffusion upon reducing rhea expression.  Evidence supporting this 
hypothesis is the fact that similar changes in integrin diffusion were measured after 
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reducing the expression of rhea or FAK (6.2-7 x 10-9 cm2/sec Brownian diffusion with 
a reduced mobile fraction).  
 
Correlations measured between integrin diffusion and lipid diffusion 
 In order to determine if changes in integrin diffusion are the result of overall 
changes in membrane viscosity, lipid diffusion coefficients were measured after 
RNAi treatment for the same target proteins. The cell line used for these 
measurements expressed wild-type integrin and had a fluorescent carbocyanine lipid 
mimetic incorporated into the cell membrane. For all lipid fluorescence recovery 
curves (Electronic supplementary material Fig. S2) except actin 42A and dreadlocks, 
the data were fit by the Brownian diffusion model or the constrained diffusion with an 
immobile fraction model generated a time exponent close to 1 (Table 1 and 3).  
Two significant changes are observed in the diffusion of the fraction of lipid 
represented by DiD after individually reducing the concentration of nine cytoplasmic 
proteins.  Reducing expression of dreadlocks, paxillin, FAK and ILK results in a 13 to 
21% increase in the lipid mobile fraction. Dreadlocks RNAi is the only one among 
this list that shows a consistent change between lipid and integrin mobile fractions. 
Second, lipid diffusion is constrained with an approximately 20% decrease in the 
time exponent when the expression of actin 42A and dreadlocks are reduced. This 
increase in constrained diffusion parallels the change measured for integrin diffusion 
when the expression of these proteins are reduced. This suggests that actin 42A 
and dreadlocks have a role in overall membrane organization and fluidity. Actin has 
been shown to affect lipid phase segregation, which indicates a possible functional 
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role in altering lipid nanodomains [44]. Under some conditions lipid nanodomain 
formation is reduced in the presence of actin.  This is consistent with the RNAi 
results indicating more constrained lipid diffusion in the absence of actin 42A. With 
these exceptions, altered integrin diffusion after reducing the expression of the other 
cytoplasmic proteins is not the result of global changes in membrane viscosity.  
 
Theory for the mechanism of altered integrin diffusion 
 The combined data in the absence of ligand and after reducing the 
expression of cytoskeletal proteins indicate that breaking the ECM-integrin-
cytoskeletal connection has a role in altering integrin dynamics. There are multiple 
modes of association between integrins and the cytoskeleton. Some of these 
interactions constrain diffusion while others release diffusion constraints (Fig. 3). 
Integrins have been shown to partition between nanodomains and the bulk 
membrane in response to a variety of stimuli including ligand binding [45]. The most 
likely explanation for how reduced expression of cytoplasmic protein alters the 
constraints to integrin diffusion is altered partitioning between nanodomains and bulk 
membrane. In some instances integrin clustering may be a separate mechanism or 
may be the result of partitioning into (e.g., ILK RNAi) or out of (e.g., rhea RNAi) 
nanodomains. With the exception of Akt1, (1) Brownian diffusion is associated with 
lower mobile fractions while (2) constrained diffusion is associated with higher 
mobile fractions. (1) If the integrins are confined in nanodomains and do not escape 
on the time scale of the FRAP experiment, the immobile fraction increases while the 
remaining integrins in the bulk membrane have fewer restrictions to diffusion. (2) If 
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the integrins partition between nanodomains and the bulk membrane on the time 
scale of the FRAP experiment and/or the nature of the nanodomains is altered on 
this time-scale, then the mobile fraction increases but diffusion is constrained. The 
nature of these nanodomains is not known at this time, but may include 
heterogeneous populations of lipid and proteins that associate with the cytoskeleton 
or are formed via interactions with the cytoskeleton. Future studies where the size of 
the photobleached area is altered may reveal if the mobile integrin is dependent on 
membrane nanodomains and selective extraction of membrane components may 
reveal the composition of these domains.   
 In no case does altering the ECM-integrin-cytoskeletal connection by the 
means employed herein lead to unrestricted lateral integrin diffusion predicted by the 
Saffman-Delbrück equation.  The ECM-integrin-cytoskeletal linkage is not 
completely dissociated and high concentrations of membrane protein are present. 
Simultaneously reducing the expression of multiple cytoplasmic proteins, including 
proteins that may not have been included in this study, as well as eliminating integrin 
interactions with other membrane proteins may be required to achieve unrestricted 
integrin diffusion. Additionally, complete elimination of the target protein expression 
may have a greater impact on integrin diffusion than reported in Table 3. Complete 
elimination of protein expression by RNAi is rarely achieved; still the other methods 
that can be used to alter protein expression are generally time consuming compared 
to the RNAi approach. Comparing all RNAi targeted proteins, there is no correlation 
between the magnitude of mRNA reduction and the magnitude change in integrin 
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diffusion coefficients. However, correlations between protein expression and integrin 
diffusion may be correlated [46]. 
 
SUMMARY 
The combination of FRAP and RNAi can be used to elucidate the molecular 
mechanism of integrin lateral diffusion. The use of RNAi to reduce the expression of 
a single protein enables the measurement of that protein's contribution to alterations 
in integrin diffusion. This is in contrast to several other methods where the entire 
cytoskeletal composition is altered or the target protein must directly bind with the 
integrin so that the interaction can be disrupted with integrin mutants. Integrins are 
linked to the cytoskeleton through a network of proteins, which is more than a simple 
anchor to the membrane. Diverse connections have functional significance in terms 
of altering integrin dynamics. This in turn affects the ability of integrins to move to 
different locations on the cell membrane in response to stimuli. For the most part, 
the mechanism by which the indicated cytoplasmic proteins alter integrin diffusion is 
more complex than simple changes in lipid viscosity, and partitioning of integrins into 
nanodomains is hypothesized to be the main factor affecting the mode of integrin 
diffusion upon altering the ECM-integrin-cytoskeletal connection. The combination of 
FRAP and RNAi should be suitable to study the diffusion of other fluorescently 
labeled membrane proteins and will be useful for unraveling the molecular 
mechanism of membrane dynamics. 
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Table 1. Real-time polymerase chain reaction results and reduced chi2 values 
obtained from integrin (top number) or lipid (bottom number) FRAP curves fit to 
different diffusion models before (control ligand or control no ligand) and after the 
indicated RNAi treatments 
  
Constrained 
Diffusion 
chi2 
 
Brownian 
Diffusion 
chi2 
Time-
dependent 
diffusion with 
an immobile 
fraction 
chi2 
Percent 
reduction in 
mRNA  after 
RNAia 
Control 
ligand 
4.7 
5.8 
1.3 
1.1 
1.2 
1.1  
Control no 
ligand 
3.0 
4.1 
1.5 
1.4 
1.0 
1.5  
Actin 42A 2.2 3.6 
2.5 
1.4 
1.4 
1.0 
90-92 
 
Dreadlocks 4.6 3.5 
4.7 
2.5 
4.0 
1.0 38-76 
Paxillin 4.4 2.1 
1.2 
1.4 
1.0 
1.3 25-43 
Integrin 
Linked 
Kinase 
1.5 
1.9 
1.2 
1.8 
1.0 
1.9 59-73 
Vinculin 2.6 1.9 
1.6 
0.4 
1.4 
0.4 84-90 
Akt1 2.6 3.2 
1.3 
0.9 
1.3 
1.0 76-80 
Rhea 3.5 3.4 
0.9 
0.4 
0.9 
0.4 32-63 
Focal 
Adhesion 
Kinase 
7.8 
2.2 
2.1 
0.9 
2.1 
1.0 78-92 
Steamer 
Duck 
7.1 
1.0 
2.0 
0.5 
1.8 
0.5 67-82 
a Measurements were performed in duplicate (n=2). Real time polymerase chain reaction results are 
expressed as a range that indicates a 95% confidence interval for expression ratios without normality 
or symmetrical distribution assumptions as determined using the software REST 2009. The p values 
for all entries in this column are 0.000 which indicates a statistically significant difference in mRNA 
concentration after RNAi treatment compared to the value measured before RNAi treatment. 
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Table 2. Integrin diffusion parameters obtained from the best-fit modela of the FRAP 
curves for a αβ-Venus cell line before (control ligand or control no ligand) and after 
the indicated RNAi treatments. 
a Mobile 
fraction 
Time 
exponent 
(α) 
Diffusion 
coefficient at 
1 s 
(x 10-9cm2/s) 
Diffusion 
coefficient 
at 50 sec 
(x 10-9cm2/s) 
Control 
Ligand 0.45 ± 0.02 0.90 ± 0.07 5.2 ± 0.9 3.6 ± 0.6 
Control 
No Ligand 0.70 ± 0.03 0.83 ± 0.05 4.1 ± 0.6 2.1 ± 0.2 
Actin 42A 0.70 ± 0.04 0.69 ± 0.06 5 ± 1 1.6 ± 0.2 
Dreadlocks 0.72 ± 0.05 0.75 ± 0.05 3.0 ± 0.7 1.1 ± 0.2 
Paxillin 0.49 ± 0.02 0.85 ± 0.06 4.6 ± 0.8 2.6 ± 0.3 
Integrin 
Linked 
Kinase 
0.49 ± 0.05 0.7 ± 0.1 5 ± 1 1.6 ± 0.4 
Vinculin 0.54 ± 0.04 0.79 ± 0.09 7 ± 1 2.9 ± 0.6 
Akt1 0.60 ± 0.02  3.1
  ± 0.5b  
Rhea 0.28 ± 0.01  7 
 ± 1b  
Focal 
Adhesion 
Kinase 
0.28 ± 0.01  6.2
  ± 0.9b  
Steamer Duck 0.32 ±  0.01 0.87 ± 0.06 6.3 ± 0.9 3.9 ± 0.6 
a Brownian diffusion assumed to be the best-fit model if the reduced chi2 was the same for time-
dependent diffusion with an immobile fraction and Brownian diffusion models 
b Brownian diffusion is not time-dependent (alpha = 1); diffusion coefficient will be the same value at 
all analysis times 
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Table 3. Lipid diffusion parameters obtained from the best-fit model to FRAP curves 
for a αβ cell line before (control ligand or control no ligand) and after the indicated 
RNAi treatments 
a Mobile 
fraction 
Time 
exponent (α) 
Diffusion 
coefficient at 1 s 
(x 10-9cm2/s) 
Diffusion 
coefficient at 50 
s (x 10-9cm2/s) 
Control 
Ligand 0.80 ± 0.03 1.1 ± 0.1 30 ± 3
b 
 
Control 
No Ligand 0.80 ± 0.01  30 ± 2
b  
Actin 42A 0.86 ± 0.06 0.8 ± 0.1 22 ± 3 12 ± 2 
Dreadlocks 1.01 ± 0.04 0.83 ± 0.07 26 ± 2 13 ± 1 
Paxillin 0.94 ± 0.02 0.96 ± 0.06 26 ± 2 22 ± 1 
Integrin Linked 
Kinase 0.96 ± 0.02  36 ± 2
b  
Vinculin 0.87 ± 0.05 1.1 ± 0.2 34 ± 5  
Akt1 0.74 ± 0.04  28 ± 4
b  
Rhea 0.87 ± 0.05 1.0 ± 0.1 29 ± 3  
Focal Adhesion 
Kinase 0.93 ± 0.03  29 ± 2
b  
Steamer Duck 0.82 ± 0.04 1.0 ± 0.1 31 ± 3  
a Brownian diffusion assumed to be the best-fit model if the reduced chi2 was the same for time-
dependent diffusion with an immobile fraction and Brownian diffusion models  
b Brownian diffusion is not time-dependent (alpha = 1); diffusion coefficient will be the same value at 
all analysis times 
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Figure 1. Experimental approach. a The cell membrane contains an array of lipids, 
proteins and small molecules. The αPS2CβPS integrin receptors that are the focus 
of this work are shown in the cell membrane in the absence of other membrane 
proteins for simplicity. Integrins are tagged with the Venus fluorescent protein (αβ-
Venus). 1 The integrin diffusion properties are measured in cells with endogenous 
levels of cytoplasmic proteins. Integrins diffusion is described by a time-dependent 
diffusion coefficient with an immobile fraction. 2 RNAi is used to reduce the 
expression of one cytoplasmic protein. 3 Changes in the integrin diffusion properties 
are measured. These studies identify the cytoplasmic proteins that have a role in 
altering integrin lateral diffusion in the cell membrane as further discussed in the 
text. b Fluorescence images of a cell expressing αβ-Venus integrins at three time 
points in the FRAP experiment. The red arrow highlights the photobleached region 
of the cell membrane. The blue arrow represents the signal that emanates from 
inside the cell. Scale bar 6.7 microns  
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Figure 2. Average fluorescence recovery after photobleaching (FRAP) curves from 
replicate measurements (blue circles) for the S2 cell line expressing αPS2CβPS-
Venus integrins at native cytoplasmic protein concentrations: a cells spread on 
ligand coated slide, b cells spread in the absence of ligand; and after the following 
RNAi treatments for cells spread on a ligand coated slide: c Actin 42A; d 
Dreadlocks; e Paxillin; f ILK; g Vinculin; h Akt1; i Rhea; j FAK and k Steamer duck. 
The data are either fit to a model that accounts for time-dependent diffusion with an 
immobile fraction (a-g and k) or a Brownian diffusion model (h-j) (red line).  All 
curves have been normalized to the pre-photobleach intensity.  
 
  
  
 
160 
Figure 3. Proposed model for the regulation of integrin dynamics. At 
endogenous cytoplasmic protein concentrations there is an immobile fraction and 
equilibrium between mobile integrins in the bulk membrane and in nanodomains. 
Upon altering the ECM-integrin-cytoskeletal connection this equilibrium is disrupted. 
In some cases immobile integrins are confined in nanodomains and do not escape. 
At the same time the remaining integrins in the bulk membrane exhibit Brownian 
diffusion. In other cases, the integrins partition between nanodomains and the bulk 
membrane. This increases the mobile fraction, but diffusion is constrained on the 
time scale of the FRAP experiment. 
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SUPPORTING INFORMATION FOR APPENDIX B 
 
 
Figure S1. Integrin and lipid FRAP curves. Average experimental FRAP curve for 
αβ-Venus cells spread on a ligand containing microscope slide (blue markers). The 
inset shows the same FRAP curve at longer analysis times. The data are fit to a 
model with time-dependent diffusion plus an immobile fraction. Experimental FRAP 
curves for αβ cells labeled with the membrane fluorophore DiD spread on a ligand 
containing microscope slide (black markers). The data are fit to a model with 
Brownian diffusion. Theoretical FRAP curve for Brownian diffusion with a 1 x 10-7 
cm2/sec diffusion coefficient (green line), the fastest diffusion that can be measured 
with the experimental method. 
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Figure S2. Average FRAP curves from replicate measurements for the S2 cell line 
expressing wild-type integrins and labeled with the membrane dye DiD (1,1'-
dioctadecyl-3,3,3',3'- tetramethylindodicarbocyanine perchlorate) at native 
cytoplasmic protein concentrations (A) cells spread on ligand coated slide, (B) cell 
spread in absence of ligand; and after the following RNAi treatments for cells spread 
on a ligand coated slide: (C) Actin 42A; (D) Dreadlocks; (E) Paxillin; (F) ILK; (G) 
Vinculin; (H) Akt1; (I) Rhea; (J) FAK and (K) Steamer Duck. The data are either fit to 
a model that accounts for time-dependent diffusion with an immobile fraction (C-E) 
or a Brownian diffusion model (A, B, F-K) (red line). The diffusion coefficients and 
mobile fractions are listed in Table S2. All curves have been normalized to the pre-
photobleach intensity. 
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Table S1. Integrin diffusion parameters obtained by fitting FRAP curves to 
constrained (time dependent) diffusion, Brownian diffusion and time-dependent 
diffusion with an immobile fraction models for a cell line expressing αPS2CβPS-
Venus integrins before (control) and after the indicated RNAi treatment. The fit 
parameters from the best-fit model, either time dependent diffusion with an immobile 
fraction or Brownian diffusion, are shown in Table 2 of the manuscript. The control 
cells were measured for cells spread on an integrin ligand containing microscope 
slide (ligand) or a slide containing only the protein BSA (no ligand). After RNAi 
treatment the cells are spread on a ligand coated microscope slide.  
 
Constrained Diffusion Brownian Diffusion Constrained/Brownian Diffusion 
 α
 
 
Diffusion 
Coefficient 
(1 s) 
(x10-9cm2/s) 
Diffusion 
Coefficient 
(50 sec) 
(x10-
9cm2/s) 
Mobile 
fraction 
Diffusion 
Coefficient 
(x10
-9
cm
2
/s) 
Mobile 
Fraction α 
Diffusion 
Coefficient 
(1 s) 
(x10-9cm2/s) 
Diffusion 
Coefficient 
(50 sec) 
(x10-
9cm2/s) 
Control 
Ligand 
0.38 
± 
0.01 
5.3 
± 0.4 
0.46 
± 0.01 
0.43 
± 0.01 
4.3 
± 0.6 
0.45 
± 0.02 
0.90 
± 
0.07 
5.2 
± 0.9 
3.6 
± 0.6 
Control 
No Ligand 
0.54 
± 
0.01 
4.9 
± 0.2 
0.81 
± 0.02 
0.63 
± 0.01 
3.0 
± 0.4 
0.70 
± 0.03 
0.83 
± 
0.05 
4.1 
± 0.6 
2.1 
± 0.2 
Actin 42A 
0.48 
± 
0.02 
5.1 
± 0.3 
0.67 
± 0.02 
0.56 
± 0.01 
3.1 
± 0.4 
0.70 
± 0.04 
0.69 
± 
0.06 
5 
± 1 
1.6 
± 0.2 
Dreadlocks 
0.57 
± 
0.01 
3.1 
± 0.2 
0.58 
± 0.01 
0.59 
± 0.01 
1.9 
± 0.3 
0.72 
± 0.05 
0.75 
± 
0.05 
3.0 
± 0.7 
1.1 
± 0.2 
Paxillin 0.41 ±0.01 
4.6 
± 0.3 
0.47 
± 0.01 
0.45 
± 0.01 
3.5 
± 0.5 
0.49 
±0.02 
0.85 
± 
0.06 
4.6 
± 0.8 
2.6 
± 0.3 
ILK 
0.42 
± 
0.03 
3.6 
± 0.6 
0.37 
± 0.02 
0.40 
±0.02 
2.9 
± 0.5 
0.49 
±0.05 
0.7 
± 0.1 
5 
± 2 
1.6 
± 0.4 
Vinculin 
0.39 
± 
0.02 
6.2 
± 0.6 
0.57 
± 0.03 
0.48 
± 0.02 
4.5 
± 0.7 
0.54 
± 0.04 
0.79 
± 
0.09 
7 
± 1 
2.9 
± 0.6 
Akt1 
0.52 
± 
0.02 
4.8 
± 0.4 
0.73 
± 0.03 
0.60 
± 0.02 
3.1 
± 0.4 
0.64 
± 0.04 
0.89 
± 
0.08 
3.8 
± 0.9 
2.5 
± 0.4 
Rhea 
0.28 
± 
0.02 
4.1 
± 0.7 
0.25 
± 0.02 
0.28 
± 0.01 
7 
± 1 
0.27 
± 0.02 
1.1 
± 0.1 
5.8 
± 2 
8.6 
± 3 
FAK 
0.28 
± 
0.01 
4.1 
± 0.4 
0.25 
± 0.01 
0.28 
± 0.01 
6.2 
± 0.9 
0.28 
± 0.01 
0.97 
± 
0.08 
6.5 
± 1 
5.9 
± 1 
Steamer 
Duck 
0.31 
± 
0.01 
4.0 
± 0.3 
0.27 
± 0.01 
0.30 
± 0.01 
5.1 
± 0.7 
0.32 
±  0.01 
0.87 
± 
0.06 
6.3 
± 0.9 
3.9 
± 0.6 
a Diffusion parameters were obtained from fitting the average FRAP curve of replicate measurements 
with the standard deviation representing the uncertainty at the 95% confidence interval of the 
corresponding coefficients obtained in the fits. 
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Table S2. Lipid diffusion parameters obtained by fitting FRAP curves to constrained 
(time dependent) diffusion, Brownian diffusion and time-dependent diffusion with an 
immobile fraction models for a cell line expressing αPS2CβPS integrins before 
(control) and after the indicated RNAi treatment. The fit parameters from the best-fit 
model either Brownian diffusion or time dependent diffusion with an immobile 
fraction, are shown in Table 3 of the manuscript. The control cells were measured 
for cells spread on an integrin ligand containing microscope slide (ligand) or a slide 
containing only the protein BSA (no ligand). After RNAi treatment the cells are 
spread on a ligand coated microscope slide. 
 
Constrained Diffusion Brownian Diffusion Constrained/Brownian Diffusion 
 α
 
 
Diffusion 
Coefficient 
(1 s) 
(x10-9cm2/s) 
Diffusion 
Coefficient 
(50 sec) 
(x10-
9cm2/s) 
Mobile 
fractio
n 
Diffusion 
Coefficient 
(x10
-9
cm
2
/s) 
Mobile 
Fraction α 
Diffusion 
Coefficien
t 
(1 s) 
(x10-
9cm2/s) 
Diffusion 
Coefficient 
(50 sec) 
(x10-
9cm2/s) 
Control 
Ligand 
0.60  
± 0.03 
22  
± 1 
4.6  
± 0.3 
0.81  
± 0.03 
30  
± 3 
0.80 
± 0.03 
1.1 
± 0.1 
30 
± 3 
37  
± 4 
Control 
No 
Ligand 
0.57  
± 0.01 
22  
± 1 
4.1  
± 0.1 
0.80  
± 0.01 
30  
± 2 
0.80 
± 0.02 
1.0 
± 0.1 
 30 
± 2 
30  
± 2 
Actin 42A 0.61  ± 0.03 
19  
± 1 
4.1  
± 0.3 
0.81  
± 0.03 
23  
± 3 
0.86 
± 0.06 
0.8 
± 0.1 
22 
± 3 
12 
± 2 
Dreadlock
s 
0.88  
± 0.02 
27  
± 1 
17 
± 0.9 
0.95  
± 0.02 
28  
± 2 
1.01 
± 0.04 
0.8
3 ± 
0.07 
26  
± 2 
13  
± 1 
Paxillin 0.71  ± 0.04 
28  
± 1 
8.0 
± 0.3 
0.92  
± 0.02 
27  
± 1 
0.94 
± 0.02 
0.9
6 ± 
0.06 
26  
± 2 
22  
± 1 
ILK 0.68  ± 0.03 
32  
± 1 
9.3  
± 0.3 
0.96  
± 0.02 
36  
± 2 
0.96 
± 0.02 
1.0
1 ± 
0.06 
36  
± 2 
37  
±  
Vinculin 0.63  ± 0.03 
29  
± 2 
6.6  
± 0.6 
0.89  
± 0.04 
34  
± 5 
0.87 
± 0.05 
1.1 
± 0.2 
35  
± 5 
47  
± 6 
Akt1 0.81  ± 0.02 
15  
± 2 
6.9  
± 0.9 
0.74  
± 0.04 
28  
± 4 
0.73 
± 0.05 
1.1 
± 0.2 
28  
± 5 
35  
±  
Rhea 0.52  ± 0.04 
25  
± 2 
3.8  
± 0.2 
0.86  
± 0.03 
29  
± 3 
0.87 
± 0.05 
1.0 
± 0.1 
29  
± 4 
24  
± 3 
FAK 0.81  ± 0.03 
26  
± 2 
12  
± 0.8 
0.93  
± 0.03 
29  
± 2 
0.93 
± 0.03 
0.9
8 ± 
0.08 
29  
± 3 
27  
± 2 
Steamer 
Duck 
0.85  
± 0.02 
22 
± 2 
12  
± 1 
0.83  
± 0.03 
31  
± 3 
0.82 
± 0.04 
1.0 
± 0.1 
31  
± 4 
37  
± 4 
a Diffusion parameters were obtained from fitting the average FRAP curve of replicate measurements 
with the standard deviation representing the uncertainty at the 95% confidence interval of the 
corresponding coefficients obtained in the fits. 
 
 
 
 
 
